,date,title,stock,close,volume,1_past_close,2_past_close,3_past_close,4_past_close,5_past_close,next_close,next_volume
0,2010-01-13,GlaxoSmithKline plc (GSK) Sees Little Threat To Advair From Generic Competition,GSK,0.0,0.5885300291150382,0.0019217813707761433,0.012895530151542323,-0.009161629557383866,0.003386871544000414,-0.011714045810384488,0.006473467927539778,0.8722987084949492
1,2010-01-15,"Market Round-up (GM, IDC, MHP, PSO, TRI, GSK, VZ, VOD, JNJ, OCR)   ",GSK,-0.025488410510594695,-0.46296043345626736,0.006473467927539778,0.0,0.0019217813707761433,0.012895530151542323,-0.009161629557383866,0.029576969405820552,-0.2829164900381518
2,2010-02-12,"Market Roundup (HA, LUV, UAUA, CHL, TSM, GSK, BP, DEO, MSFT, YHOO, GOOG, AAPL, RIMM)",GSK,0.007277979079381325,-0.5418335317675074,0.025319810617556504,-0.009921618090904971,0.009181446413736305,0.0015761033478949305,-0.011171445914929579,0.012903524490341933,1.1597566737538387
3,2010-02-16,GlaxoSmithKline (GSK) Shares Rise With Upgrade,GSK,0.012903524490341933,1.1597566737538387,0.007277979079381325,0.025319810617556504,-0.009921618090904971,0.009181446413736305,0.0015761033478949305,0.0028029947877574735,-0.5809292023298422
4,2010-03-18,"US Stock Futures Mixed (PFE, TEVA, GSK, NKE, NVS, FDX)",GSK,0.037565952485934195,1.0629032258064517,0.000264644309752482,0.0015899901491480684,-0.0023794102274196094,-0.0005286889880481427,0.004779639657691126,-0.016572951774041167,-0.17507668250436037
5,2010-03-22,FDA Asks Doctors To Suspend Use Of GlaxoSmithKline (GSK) Rotavirus Vaccine,GSK,0.011407592469122596,-0.33369787109944593,-0.016572951774041167,0.037565952485934195,0.000264644309752482,0.0015899901491480684,-0.0023794102274196094,-0.0007690067526983091,-0.06127585074953501
6,2010-05-28,"Afternoon Market Update (AAPL, AMGN, GSK)",GSK,0.0029973349444936126,-0.20222669223932266,0.03154022696867642,-0.01761824655031141,-0.0003041118297916201,-0.010516400355268685,-0.0015000732971286457,0.005977089958319359,0.5939369062976427
7,2010-07-09,"News Summary (BA, EAD, GSK)",GSK,-0.0020051605533379924,0.24491063418673664,0.01364687438676615,0.00908267029829224,0.010361403666449887,-0.004127476876475189,-0.002646145268538902,0.008036971309851593,-0.2257483370288248
8,2010-07-13,GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth ,GSK,0.017084361929046388,0.4213352425272956,0.008036971309851593,-0.0020051605533379924,0.01364687438676615,0.00908267029829224,0.010361403666449887,0.0176366896438811,2.3868278554338245
9,2010-08-13,All Is Not Well In The Pharmaceutical Industry,GSK,0.025268668814776518,0.4508169755455642,0.020296367509691438,-0.02513374160105497,0.015200937109387747,0.008762042135651127,0.009956022483621041,-0.0023596706618915775,-0.3216553287981859
10,2010-08-13,"U.S. Probing Pharmaceutical Corruption (GSK, PFE, BMY, LLY)",GSK,0.025268668814776518,0.4508169755455642,0.020296367509691438,-0.02513374160105497,0.015200937109387747,0.008762042135651127,0.009956022483621041,-0.0023596706618915775,-0.3216553287981859
11,2010-09-23,Travelers Mad As Hell ,GSK,-0.017932867182128387,2.881962251460759,-0.004956176766380049,0.000495836027482266,0.012807511747509936,-0.0022557564189077395,-0.0032459093411661977,0.026375810254736676,-0.7369515311647248
12,2011-03-23,POZEN Announces Licensing Deal with a Division of Johnson & Johnson for Migraine Treatment   ,GSK,-0.009478994529653173,0.5453566621803498,0.0044962495758322785,0.012587174917815025,0.0,0.020218529755616332,-0.026854149371828617,0.00026627439314608203,-0.049686465772513455
13,2011-03-30,A Peek Into The Market Before The Trading Starts,GSK,0.008914599240894328,-0.032226704904486425,0.008727846846203091,0.002385940796181485,0.0023915517905157557,0.00026627439314608203,-0.009478994529653173,-0.0018191937214379061,0.3985936715218483
14,2011-05-06,"UPDATE: FDA Approves New Treatment for Rare Type of Pancreatic Cancer (PFE, MRK, GSK)",GSK,0.0027990759313367697,-0.06510618508758337,-0.008556940214994202,0.004787349546516717,-0.0013760003098072238,-0.0009157011474749677,0.002525503418082886,-0.004884607400667096,0.6374288398828276
15,2011-06-13,"Benzinga's Political Roundup June 13, 2011",GSK,0.0098627323017495,-0.2940579442701605,-0.016094936442449193,-0.0030674536972419286,-0.010506561833841355,0.007527828988724616,-0.002580642592283189,0.009052035941664593,0.00751535746961185
16,2011-07-21,"Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter",GSK,0.02307706888992178,-0.07121893954216396,0.0006999545487271774,-0.0013975408749203888,-0.008086817509600719,0.01334581365381493,-0.016804832900289557,-0.0031901386603866433,-0.39830419212133983
17,2011-07-25,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",GSK,0.009828700030370285,1.3534354485776805,-0.0031901386603866433,0.02307706888992178,0.0006999545487271774,-0.0013975408749203888,-0.008086817509600719,0.016070634862582756,0.710093722106516
18,2011-07-26,Earnings Roundup,GSK,0.016070634862582756,0.710093722106516,0.009828700030370285,-0.0031901386603866433,0.02307706888992178,0.0006999545487271774,-0.0013975408749203888,-0.013143491563512688,-0.280093951849677
19,2011-07-26,"Earnings Preview: Merck EPS, Revenue Expected to Rise from Previous Quarter",GSK,0.016070634862582756,0.710093722106516,0.009828700030370285,-0.0031901386603866433,0.02307706888992178,0.0006999545487271774,-0.0013975408749203888,-0.013143491563512688,-0.280093951849677
20,2011-07-26,"Amgen Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",GSK,0.016070634862582756,0.710093722106516,0.009828700030370285,-0.0031901386603866433,0.02307706888992178,0.0006999545487271774,-0.0013975408749203888,-0.013143491563512688,-0.280093951849677
21,2011-07-28,Pfizer Earnings Preview: Analysts Expect Falling EPS,GSK,0.01376995756342847,-0.10322639115461296,-0.013143491563512688,0.016070634862582756,0.009828700030370285,-0.0031901386603866433,0.02307706888992178,-0.010910597608859152,-0.020043793161529377
22,2011-08-22,"Goldman Sachs CEO Shows Signs of Fear, Hires High-Profile Defense Attorney",GSK,0.01641373766367682,0.40333735424205863,-0.011143336507535406,-0.02180104855260201,0.008363201512616047,-0.006174597232399881,0.019612766342632426,0.04434823234262608,-0.312469556746225
23,2011-10-14,"Abbott Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",GSK,-0.003880795413927274,-0.36145194274028625,0.009447320519385682,0.001384480261643617,-0.009371423296143377,0.020289262750393222,0.012036837070400486,-0.00939528538443557,-0.18362690152121697
24,2011-10-14,"Johnson & Johnson Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",GSK,-0.003880795413927274,-0.36145194274028625,0.009447320519385682,0.001384480261643617,-0.009371423296143377,0.020289262750393222,0.012036837070400486,-0.00939528538443557,-0.18362690152121697
25,2011-10-19,Human Genome Sciences Spokesperson Comments on Recent Rumors,GSK,-0.0016128864758966355,-0.1402493321460374,0.003932784231168496,-0.00939528538443557,-0.003880795413927274,0.009447320519385682,0.001384480261643617,0.01476995989451213,0.2138788192646297
27,2011-10-24,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",GSK,-0.006222002618679112,-0.13593909204120913,0.023425407200081905,0.01476995989451213,-0.0016128864758966355,0.003932784231168496,-0.00939528538443557,-0.015876855267313084,0.003603131448786323
28,2011-10-25,"Merck Earnings Preview: Analysts Expect Higher EPS, Revenue",GSK,-0.015876855267313084,0.003603131448786323,-0.006222002618679112,0.023425407200081905,0.01476995989451213,-0.0016128864758966355,0.003932784231168496,0.018632516222863327,0.14882992264760597
29,2011-10-27,"Pfizer Earnings Preview: Analysts Expect Higher EPS, Revenue",GSK,-0.0017849567804781863,0.10380976732293523,0.018632516222863327,-0.015876855267313084,-0.006222002618679112,0.023425407200081905,0.01476995989451213,0.004022494929037723,-0.3897768512084009
30,2012-01-06,"Benzinga's M&A Chatter for Friday January 6, 2012",GSK,0.001084410556625004,-0.1755732423725601,-0.004746836621002171,0.001512522938365457,0.01424507715566703,-0.0010945641481820978,0.008610811262183438,-0.0394110460619963,1.568382944489139
31,2012-01-17,Taking a Closer Look at Investing in Singapore,GSK,0.009743875126016821,-0.4052181663493093,-0.010315994961563657,0.0038272367852236755,0.01577886391643224,-0.014202437690626901,-0.0394110460619963,0.021095094455282792,0.598392480076289
32,2012-01-25,"Benzinga's M&A Chatter for Wednesday January 25, 2012",GSK,0.00987197272071172,-0.03072299215227914,-0.008012566973632063,0.0015608625634822015,0.004028469436472948,-0.018022318243371194,0.021095094455282792,0.009775622879433232,0.33563020384725806
33,2012-02-09,"Benzinga's M&A Chatter for Thursday February 9, 2012",GSK,0.016009234474885226,0.035605956156073315,-0.01004458328458413,-0.006431695453970487,0.00535113804392795,0.010134915899736141,-0.017264094368057314,-0.006880056153596548,-0.16841404559826922
34,2012-03-08,"Benzinga's M&A Chatter for Wednesday March 7, 2012",GSK,0.0029176712172491737,0.2388038447846208,0.010892202994627453,-0.015195954912985976,0.011756962512482705,-0.018855059373914185,0.01737734160739124,-0.0020140498919265504,-0.07454451405253171
35,2012-03-21,"Benzinga's M&A Chatter for Wednesday March 21, 2012",GSK,-0.0024167965199083374,0.31916709336064164,0.00043959717346919724,0.006861483584530204,0.0037766488229984407,-0.0004440125461195876,-0.009459064037639187,-0.002643258995498887,-0.07601242075300818
36,2012-04-30,FDA Considering Letting Patients Purchase Drugs Without Prescriptions,GSK,-0.006020483324398418,-0.36152889290964607,0.006710143944380409,0.004347897822449154,-0.02563061360001584,0.00042383258820977154,-0.0021146100900160114,0.007571497841447394,-0.22499704805762188
37,2012-05-11,The Shorts Report: 10 Mega-Caps With Increased Short Selling,GSK,0.0026368229021520584,0.16830079290647104,0.0,-0.011320670979608094,0.0,0.010633182128207075,-0.017483291700600034,-0.0006573252981505462,0.7288185068963
38,2012-06-14,Johnson & Johnson to Complete Synthes Acquisition ,GSK,0.005325523308720159,-0.3230160081743869,-0.0052973123483355256,0.02049552688304379,-0.004930417065378334,0.007906079418992462,-0.0024786907587702744,-0.0052973123483355256,0.6932268410791773
39,2012-06-28,Ultimate Stock Watch List for The Supreme Court's Health Care Ruling,GSK,-0.011857638345118438,0.5043401996941621,-0.011719041500539595,0.00479732336414096,-0.0006536765566954594,0.004817577092523839,-0.008467738740473574,0.01266668283760719,-0.655669332536064
40,2012-07-16,Benzinga's Top Pre-Market Gainers,GSK,0.006666941473447485,0.04958721989921733,0.011917816264175762,-0.023495440269120982,0.012224596057845094,-0.03434187229156216,0.007133509842893071,0.003090244999241598,-0.1237550436692374
43,2012-08-06,Teva Pharmaceutical Subpoenaed By SEC in Bribery Charge,GSK,0.011782162863703816,0.7937739270602457,0.008425232543984196,0.0012979555877707938,0.00499977835861487,-0.0008687775697427957,0.006999380436740754,-0.0012703322097024072,-0.23111485537770293
45,2012-12-11,"Benzinga's M&A Chatter for Tuesday December 11, 2012",GSK,0.009097244361305545,0.6205014544950824,0.015004695469972296,-0.0032214562346905007,-0.0013788276670292365,-0.0018346644613538299,0.0069284893847541,-0.003606165850946863,0.19744580455446892
48,2013-01-07,4 Health Care ETFs Your Broker Forgot to Mention,GSK,0.0002257287204192604,-0.031533967979229804,0.006366883413688074,-0.00339923618208271,0.015183202960471043,0.005551630740061597,-0.0057502368201893805,0.0,-0.168891371125384
52,2013-03-04,The News of an HIV Cure Is Great News For These Publicly-Traded Companies,GSK,0.0020351553553816792,0.0328144877647234,0.004315548864691543,-0.005421508969343569,0.0018103441874388615,-0.001355971585884741,-0.01971626554491268,0.006770460255092425,-0.11415425859508022
56,2013-03-04,An HIV Cure Is Great News For These Publicly-Traded Companies,GSK,0.0020351553553816792,0.0328144877647234,0.004315548864691543,-0.005421508969343569,0.0018103441874388615,-0.001355971585884741,-0.01971626554491268,0.006770460255092425,-0.11415425859508022
59,2013-03-04,An HIV Cure Is Great News For These Drug Manufacturers,GSK,0.0020351553553816792,0.0328144877647234,0.004315548864691543,-0.005421508969343569,0.0018103441874388615,-0.001355971585884741,-0.01971626554491268,0.006770460255092425,-0.11415425859508022
62,2013-03-26,13 Drugs Pending FDA Approval in 2013,GSK,-0.007336596048253208,0.618827077387043,-0.0021535177529264926,0.00912631336115588,0.00261438522347035,0.003059177444454164,0.01418481283004569,0.008260829579783024,-0.021057884231536872
68,2013-03-26,14 Drugs Pending FDA Approval in 2013 [DRAFT],GSK,-0.007336596048253208,0.618827077387043,-0.0021535177529264926,0.00912631336115588,0.00261438522347035,0.003059177444454164,0.01418481283004569,0.008260829579783024,-0.021057884231536872
69,2013-03-26,15 Drugs Pending FDA Approval in 2013,GSK,-0.007336596048253208,0.618827077387043,-0.0021535177529264926,0.00912631336115588,0.00261438522347035,0.003059177444454164,0.01418481283004569,0.008260829579783024,-0.021057884231536872
71,2013-03-26,16 Drugs Pending FDA Approval in 2013,GSK,-0.007336596048253208,0.618827077387043,-0.0021535177529264926,0.00912631336115588,0.00261438522347035,0.003059177444454164,0.01418481283004569,0.008260829579783024,-0.021057884231536872
78,2013-04-02,"Benzinga's M&A Chatter for Tuesday April 2, 2013",GSK,0.0017059646878687662,0.46936431804363976,-0.0004264293183118273,0.011427289987434142,0.008260829579783024,-0.007336596048253208,-0.0021535177529264926,0.0,-0.2752517125649395
79,2013-04-11,Likely Winners and Losers in Obama's 2014 Budget,GSK,0.016125346282316766,0.6688830658368818,0.00908757223219081,0.005310949149162081,0.0059842909697760405,-0.004044357897837747,0.00021307933126379908,-0.0010306324737678896,-0.24058409059684793
83,2013-04-17,Intel Expands Its Pharmaceutical R&D ,GSK,0.01944078594189924,1.9071128176997623,0.0030469784386428778,0.01568012970799959,-0.0010306324737678896,0.016125346282316766,0.00908757223219081,0.0009933708599667579,-0.13363104597773445
84,2013-09-19,Write A Prescription For Health Care ETFs,GSK,-0.019504647061998948,0.3036079522212223,0.0027379422099045314,-0.0033138503255726315,-0.0021394236393205146,0.0037095007947789416,-0.0017542948867348418,0.005171900084048886,-0.268262834191038
86,2013-11-12,Gilead Sciences Leads In Rising Short Interest Among Biotechs ,GSK,-0.016028890632121207,0.3216973786659745,-0.0024453370680902475,0.008345825006132124,-0.011437840773901753,-0.006520374498627857,0.005996901885893857,0.007291981511572843,-0.28515791196203566
88,2013-11-18,13F roundup ,GSK,-0.0013440550254227857,-0.245610453246223,-0.0009591014754907201,0.003658085546186074,0.007291981511572843,-0.016028890632121207,-0.0024453370680902475,0.011344154764601821,0.5692828146143436
89,2013-11-18,2013 3Q 13F Roundup,GSK,-0.0013440550254227857,-0.245610453246223,-0.0009591014754907201,0.003658085546186074,0.007291981511572843,-0.016028890632121207,-0.0024453370680902475,0.011344154764601821,0.5692828146143436
94,2013-12-17,Market Wrap For December 17: Markets Relatively Calm Before The Potential Storm,GSK,-0.016188016985458353,0.2366442227355383,0.01012267501007269,0.0015597309747672483,-0.002722144407295457,-0.011341913497513456,-0.009331517933316658,0.005680521627196011,0.9253239011207377
98,2013-12-18,Merck Collaborates with GlaxoSmithKline on MK-3475,GSK,0.005680521627196011,0.9253239011207377,-0.016188016985458353,0.01012267501007269,0.0015597309747672483,-0.002722144407295457,-0.011341913497513456,0.004479852240450333,-0.3986582722675198
99,2014-01-07,Market Wrap For January 7: Markets Reverse Three Day Slump,GSK,0.0013209003538603437,-0.17240956468424284,0.003787841734003816,0.0001891980525214887,-0.011237602551544379,0.005082588251777542,0.002264199326563965,-0.0064070032391482235,0.2953030078530152
101,2014-01-07,Market Wrap For January 7: Markets Reverse 3-Day Slump,GSK,0.0013209003538603437,-0.17240956468424284,0.003787841734003816,0.0001891980525214887,-0.011237602551544379,0.005082588251777542,0.002264199326563965,-0.0064070032391482235,0.2953030078530152
103,2014-01-31,Benzinga Weekly Preview:  Twitter To Release Earnings For The First Time Since Going Public,GSK,-0.008083015720631082,0.0441770186335404,-0.0015376702913943996,-0.02290639933634786,0.0028242695963580644,-0.004124880133433706,-0.028597609156222337,-0.010476920029646397,0.23849356829504043
104,2014-01-31,Benzinga Weekly Preview: Twitter To Release Earnings For The First Time Since Going Public,GSK,-0.008083015720631082,0.0441770186335404,-0.0015376702913943996,-0.02290639933634786,0.0028242695963580644,-0.004124880133433706,-0.028597609156222337,-0.010476920029646397,0.23849356829504043
107,2014-02-03,Market Wrap For January 3: Bears In Complete and Absolute Control,GSK,-0.010476920029646397,0.23849356829504043,-0.008083015720631082,-0.0015376702913943996,-0.02290639933634786,0.0028242695963580644,-0.004124880133433706,-0.0019610086110991576,-0.31231050941074057
109,2014-02-03,Market Wrap For February 3: Bears In Complete and Absolute Control,GSK,-0.010476920029646397,0.23849356829504043,-0.008083015720631082,-0.0015376702913943996,-0.02290639933634786,0.0028242695963580644,-0.004124880133433706,-0.0019610086110991576,-0.31231050941074057
113,2014-02-18,Berkshire Hathaway Files SEC 13F,GSK,0.01377724526576296,0.7087319243604004,0.015074561887315818,0.004560967689928752,0.01181514383228821,0.022075121540444664,0.003027601484358433,-0.0035771283007300925,-0.17654525925202613
115,2014-02-20,Market Wrap For Febuary 20: S&P 500 Inches Closer to New Highs,GSK,0.009154148156974129,0.19115380054547604,-0.0035771283007300925,0.01377724526576296,0.015074561887315818,0.004560967689928752,0.01181514383228821,-0.009427287273839347,-0.37723577235772354
117,2014-02-20,Market Wrap For Febuary 20: S&P 500 Inches Closer To New Highs,GSK,0.009154148156974129,0.19115380054547604,-0.0035771283007300925,0.01377724526576296,0.015074561887315818,0.004560967689928752,0.01181514383228821,-0.009427287273839347,-0.37723577235772354
120,2014-03-10,Market Wrap For March 10: Markets Slightly Lower on Chinese Growth Concerns,GSK,0.005582656995295254,-0.12787759040573454,-0.005729554515921831,-0.01027818925670565,0.0,0.011290111009429227,-0.0025025373344366164,-0.00340269660104231,-0.02818756585879878
122,2014-03-10,Market Wrap For March 10: Markets Slightly Lower On Chinese Growth Concerns,GSK,0.005582656995295254,-0.12787759040573454,-0.005729554515921831,-0.01027818925670565,0.0,0.011290111009429227,-0.0025025373344366164,-0.00340269660104231,-0.02818756585879878
124,2014-03-20,Market Wrap For March 20: Investors Showing No Post-Fed Decision Hangover,GSK,-0.012611391949149953,0.5271859887596393,-0.0007308079633842057,0.0036661980122900673,0.005900938869108696,-0.0023916007956037433,-0.011276453427236599,-0.017586231198734148,0.24006162009499765
126,2014-03-20,Market Wrap For March 20: Investors Showing no Post-Fed Decision Hangover,GSK,-0.012611391949149953,0.5271859887596393,-0.0007308079633842057,0.0036661980122900673,0.005900938869108696,-0.0023916007956037433,-0.011276453427236599,-0.017586231198734148,0.24006162009499765
129,2014-04-02,Market Wrap For April 2: Markets on Four-day Winning Streak,GSK,-0.005628441307125587,0.18970418747598927,-0.0024332289990053324,-0.008719902261813295,-0.00037080093000885217,0.00615783824711813,-0.005566819726197436,-0.0052829466417523285,-0.2804507879101007
131,2014-04-02,Market Wrap For April 2: Markets On Four-Day Winning Streak,GSK,-0.005628441307125587,0.18970418747598927,-0.0024332289990053324,-0.008719902261813295,-0.00037080093000885217,0.00615783824711813,-0.005566819726197436,-0.0052829466417523285,-0.2804507879101007
133,2014-04-22,US Stock Futures Edge Higher Ahead Of McDonald's Earnings,GSK,0.04103953584371767,2.2483811850946855,0.011616382916844525,-0.005868735492224775,0.009556326330516951,0.009259250485059711,0.0015458114204975892,-0.0028934917865607312,-0.576199789378667
136,2014-04-22,"Market Wrap For April 22: S&P Rises for Sixth Straight Day, Dow and Nasdaq Also Positive",GSK,0.04103953584371767,2.2483811850946855,0.011616382916844525,-0.005868735492224775,0.009556326330516951,0.009259250485059711,0.0015458114204975892,-0.0028934917865607312,-0.576199789378667
137,2014-04-22,"Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive",GSK,0.04103953584371767,2.2483811850946855,0.011616382916844525,-0.005868735492224775,0.009556326330516951,0.009259250485059711,0.0015458114204975892,-0.0028934917865607312,-0.576199789378667
140,2014-04-25,Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report,GSK,0.004503797929319431,-0.16101221361858387,0.006710268862886837,-0.0028934917865607312,0.04103953584371767,0.011616382916844525,-0.005868735492224775,0.004483384431053228,0.5350618458610847
141,2014-04-25,Benzinga Weekly Preview: Earnings Season Continues As Biotech and Pharmaceutical Companies Report,GSK,0.004503797929319431,-0.16101221361858387,0.006710268862886837,-0.0028934917865607312,0.04103953584371767,0.011616382916844525,-0.005868735492224775,0.004483384431053228,0.5350618458610847
144,2014-04-30,"#PreMarket Primer: Wednesday, April 30: No BOJ Stimulus On The Horizon ",GSK,-0.018088501908422927,-0.03589591665432279,0.006784630173246153,0.004483384431053228,0.004503797929319431,0.006710268862886837,-0.0028934917865607312,0.0005419686937944146,-0.5587934036669057
146,2014-05-12,Google Celebrates Dorothy Hodgkins and Her Contributions in Chemistry,GSK,0.00272756387207318,0.9305905920759756,0.0016396018828745973,-0.009919097743161909,0.0005413688454749543,0.002351039820632783,0.0029023025505332534,0.006891678647433563,0.5109432947099402
148,2014-06-04,"ASCO Meeting Day 2: ""Promising"" Results from JNJ's Imbruvica & Targeted Therapy",GSK,-0.0024427274058549386,-0.09034006335636047,-0.008199820848432737,-0.0051905738539653745,-0.008091588739147948,0.011156355219686498,-0.021469763772188122,0.003955685891169791,-0.10892003020894525
149,2014-06-04,"ASCO Meeting Day 2: ""Promising"" Results From JNJ's Imbruvica & Targeted Therapy",GSK,-0.0024427274058549386,-0.09034006335636047,-0.008199820848432737,-0.0051905738539653745,-0.008091588739147948,0.011156355219686498,-0.021469763772188122,0.003955685891169791,-0.10892003020894525
153,2014-06-18,"Advances In HIV, Hep C Treatments Spark Renewed Interest In Biotech Stocks",GSK,-0.0018498988917339254,0.0392866209697893,-0.006251097834061303,-0.0020186099690264747,0.0018383314876750934,0.0018416051866756433,0.005555847802951597,0.008897051394760158,-0.2324274809160305
156,2014-06-18,"Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks",GSK,-0.0018498988917339254,0.0392866209697893,-0.006251097834061303,-0.0020186099690264747,0.0018383314876750934,0.0018416051866756433,0.005555847802951597,0.008897051394760158,-0.2324274809160305
161,2014-07-15,Morning Market Movers ,GSK,-0.00485251734462,0.004485631192389317,-0.0024205552936241714,-0.012683884752816565,0.009838815191263173,0.00955781566192293,-0.01386115379343189,-0.00018737459505568932,0.5979978408087152
164,2014-07-28,Markets Little Changed Ahead Of The Federal Reserve's Policy Decision,GSK,-0.0082305102383059,-0.3563982813375677,-0.0295531867612302,0.0007995356713115243,-0.05975181761820281,-0.0031839204626973316,-0.006142857740083274,-0.003527068235425035,-0.21988563798908622
171,2014-08-04,"Glaxo, Sanofi Trend Up On Potential Deal For Established Brands",GSK,0.010410645461408796,-0.26498730357340006,-0.0070292811947764156,-0.002063302493682584,0.009161246686783864,-0.003527068235425035,-0.0082305102383059,0.00309072026608348,0.17236199774690197
173,2014-08-04,"Glaxo, Sanofi, Trend Up On Potential Deal For Established Brands",GSK,0.010410645461408796,-0.26498730357340006,-0.0070292811947764156,-0.002063302493682584,0.009161246686783864,-0.003527068235425035,-0.0082305102383059,0.00309072026608348,0.17236199774690197
175,2014-08-28,Markets Reverse Early Morning Losses But Still Lower On The Day,GSK,0.004109393758749302,-0.023308759757155295,0.008495105495112787,0.00270131359446113,0.009438259574936048,-0.00041954076890404757,-0.0023009435202513417,0.004706483562540331,-0.11451511451511454
177,2014-08-28,Markets Reverse Early Morning Losses; Still Lower On The Day,GSK,0.004109393758749302,-0.023308759757155295,0.008495105495112787,0.00270131359446113,0.009438259574936048,-0.00041954076890404757,-0.0023009435202513417,0.004706483562540331,-0.11451511451511454
180,2014-10-30,Ebola Vaccine Contenders,GSK,0.0013309085237529494,0.2065584415584416,-0.0004433952041610345,-0.005951202358304486,-0.00917236084950035,0.009479939175655039,0.021391467242160234,0.007754264941907563,-0.043700554329691665
188,2014-12-11,Market Shrugs Off Plan To Spend $300 Million On Ebola Vaccines,GSK,-0.0032193776182406486,-0.659384512314123,-0.014055398224339433,-0.031826501300497134,-0.01042570065692805,0.0032688544949679432,-0.017554997479042433,-0.021453126378919052,0.04639329542053283
189,2014-12-11,Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines,GSK,-0.0032193776182406486,-0.659384512314123,-0.014055398224339433,-0.031826501300497134,-0.01042570065692805,0.0032688544949679432,-0.017554997479042433,-0.021453126378919052,0.04639329542053283
192,2015-01-12,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2,GSK,0.0030377755125932104,0.4149284192202647,-0.009030278265430347,0.025647058889556762,0.01031704860723992,-0.005488331137371127,-0.010856724715013644,-0.0004662840375820876,-0.3181104700492109
193,2015-01-12,Biotechs Presenting at the J.P. Morgan Healthcare Conference: Day Two,GSK,0.0030377755125932104,0.4149284192202647,-0.009030278265430347,0.025647058889556762,0.01031704860723992,-0.005488331137371127,-0.010856724715013644,-0.0004662840375820876,-0.3181104700492109
200,2015-10-19,The 15 Largest Mergers In History,GSK,-0.005243334362697083,0.26063864450961227,0.010110701172511227,0.022648948558369186,0.012715070411491336,-0.006686136527677244,0.0039777876243725085,-0.013895463429770771,-0.09656491509214504
212,2016-01-29,"Benzinga's M&A Chatter for Thursday January 28, 2015",GSK,0.015993832827601695,-0.2255463254003892,0.0009853699390196535,-0.0056333259277907555,0.02898211242411075,-0.00874362180835453,0.02535845807785453,0.002179643383659835,-0.27864614789940323
215,2016-02-29,25 Headlines Moving The Markets This Week,GSK,-0.012008093458313995,-0.03254092621611704,-0.009113944578737931,0.02490917070395393,-0.0025879858381689935,-0.018292655640821276,-0.010060339821344688,0.025601069595909465,0.17696522728055974
222,2016-04-05,"The Market In 5 Minutes: Tuesday, April 5, 2016",GSK,-0.01488894814970021,0.05943078169511007,0.015617202775904948,-0.005178952207909204,-0.0036851626978259278,0.011430950231070769,0.0174463907505078,0.03270538519314092,0.15709105261859535
227,2016-04-06,SocGen Picks New Favorites In Big Pharma,GSK,0.03270538519314092,0.15709105261859535,-0.01488894814970021,0.015617202775904948,-0.005178952207909204,-0.0036851626978259278,0.011430950231070769,-0.00359851586494242,-0.14004903528408486
231,2016-05-03,The Market In 5 Minutes: Do Or Die,GSK,-0.0034649953532782662,0.7003439380911436,0.008855902049699438,-0.010378268186763684,-0.0025309477271587832,0.017794611228787005,-0.006050504849856697,-0.018312704379776834,-0.22749109297781867
234,2016-05-03,The Market In 5 Minutes,GSK,-0.0034649953532782662,0.7003439380911436,0.008855902049699438,-0.010378268186763684,-0.0025309477271587832,0.017794611228787005,-0.006050504849856697,-0.018312704379776834,-0.22749109297781867
236,2016-10-25,6 Big Pharma Companies Left To Report September Quarterly Figures,GSK,-0.008849382041830056,1.0990595003393557,-0.010940847558484235,-0.0072411671511262155,-0.0014459863170580567,-0.0064657528277694,0.013838329630398771,0.0004957630884767639,-0.16410303786164104
237,2016-10-26,"Earnings Scheduled For October 26, 2016",GSK,0.0004957630884767639,-0.16410303786164104,-0.008849382041830056,-0.010940847558484235,-0.0072411671511262155,-0.0014459863170580567,-0.0064657528277694,0.0019829875845938094,-0.08172926375508849
238,2016-12-12,What We Know About Trump's Potential Pick To Head The FDA,GSK,0.0007938073618507513,-0.4083186248177423,0.010698214652497873,-0.004261023876491743,-0.0037147711568639163,0.0005311220595378696,-0.0007957717665280084,0.016657769105381748,0.18471634977043405
239,2016-12-19,Jefferies' 2017 Global Pharma Outlook,GSK,-0.00596731335791445,-0.33688881813297245,0.011017509178914864,0.004214862983555223,-0.01274369204171888,0.016657769105381748,0.0007938073618507513,-0.00026126103996770844,0.04753616229518043
240,2016-12-23,6 Worst Biotech Stocks Of 2016,GSK,0.001828553541629141,-0.4250270002043258,0.003933919691933463,-0.004438503356296919,-0.00026126103996770844,-0.00596731335791445,0.011017509178914864,-0.0018252160363816383,0.19265915321352423
241,2017-03-10,How The Ultra-Wealthy Are Helping Advance Health And Life Sciences,GSK,-0.0019304015608391234,0.15484836480478892,0.007780430168665031,-0.007480435184377132,-0.009086621148805096,-0.0040489200250352075,0.007921282686444542,0.006768476287776437,-0.17189465258985404
242,2017-04-20,What Would A $5.8 Billion NIH Cut Look Like? Devastation.,GSK,-0.0031831890553993825,-0.010411601498812928,-0.010658751229111307,-0.013384273395585233,0.0007170509537763881,-0.0011941914704233225,0.0019147845006728392,0.0017197419076389053,-0.06483221088533686
243,2017-05-23,"Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst",GSK,-0.007852069519229454,-0.021919099667088937,-0.00688083044465071,0.00832526685375723,0.00023161875341015659,-0.0043759829326338595,0.0006915894084531526,-0.00023260001266789398,-0.4401337389680412
244,2017-05-30,Alternative Paths To The Public Markets: Nexeon MedSystems' Form 10 IPO And Capital Consciousness,GSK,0.017342638469429295,-0.15599564831976787,0.0023491051555226683,-0.008847738016977691,-0.00023260001266789398,-0.007852069519229454,-0.00688083044465071,0.018889447764111056,0.3750268541283748
245,2017-07-26,"Earnings Scheduled For July 26, 2017",GSK,-0.026454008674319462,0.37710158654984616,-0.006628818722897889,-0.009845244982641055,-0.0025718127464408047,0.008251001104169653,-0.00023580567810710384,-0.002447890029563249,-0.21053649729172041
246,2017-08-01,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,GSK,0.0022213454268220634,-0.5410463872045654,-0.010017365915869991,0.004417239501037562,-0.002447890029563249,-0.026454008674319462,-0.006628818722897889,0.0034474120192835578,-0.2574034685863874
247,2017-09-01,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,GSK,-0.0007455172794692544,0.005749264432344692,0.012329768531109231,0.010681737008431336,-0.003547734450093154,-0.00025341824555269454,0.00025348248263878936,-0.00771155430537418,0.3187733279531928
248,2017-09-28,"Biotech Investors, Here's Your PDUFA Primer For October",GSK,-0.00024745902814893306,0.05253799349873578,-0.0004951089080809101,-0.005903939393114066,0.0017249086620649834,0.00619911181524313,0.003733038872002048,0.0054482503768578106,-0.17682926829268297
249,2017-10-23,The Week Ahead: Earnings Season Starts In Earnest,GSK,-0.00538645481168476,-0.2339526744613738,-0.006326339441509066,0.002194503647330759,0.004408603204202999,-0.0007343302792690576,-0.0036576083438385476,-0.003446667775124479,-0.363398274381993
250,2017-10-25,"Earnings Scheduled For October 25, 2017",GSK,-0.05657108792179477,3.9382442346810507,-0.003446667775124479,-0.00538645481168476,-0.006326339441509066,0.002194503647330759,0.004408603204202999,-0.0416340512158776,-0.37624674284815074
251,2017-12-01,GlaxoSmithKline Begins Phase III Study On Injection To Prevent HIV,GSK,0.0074158208566670325,0.029000992139204707,-0.011558979360389632,-0.012527630924085376,0.010407641466049444,0.014554842057910022,-0.0005705620960332336,-0.00906017693456973,-0.21478899354743008
252,2017-12-04,"The Week Ahead For December 4: The Biggest Catalysts, Conferences, And Investor Events",GSK,-0.00906017693456973,-0.21478899354743008,0.0074158208566670325,-0.011558979360389632,-0.012527630924085376,0.010407641466049444,0.014554842057910022,-0.003999789563125078,0.41574572589024283
253,2018-01-19,Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings?,GSK,0.000786143895279201,-0.19417543209304478,0.0005238284031039431,0.006065703807301093,0.011199806345160601,0.01791544471612494,0.012087613466887026,0.009424367427810498,0.21672752364796866
254,2018-03-23,25 Stocks Moving In Friday's Pre-Market Session,GSK,0.03513133863325235,1.6985046985389944,-0.016594133433547542,0.0,-0.003524095911580649,-0.01046110114739951,0.009750741066230306,0.00026716962429329527,-0.6266283695334443
255,2018-04-25,"Earnings Scheduled For April 25, 2018",GSK,-0.03740165880041091,0.46443152294940004,0.007686833196475673,0.008249879162462115,0.003009066524582993,-0.013847874400584326,-0.0017275348818390768,0.027607347619602596,-0.32969502407704654
256,2018-04-30,Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning,GSK,-0.011094708759234795,-0.5081053175012906,0.008955704727304559,0.027607347619602596,-0.03740165880041091,0.007686833196475673,0.008249879162462115,-0.0017457344918376805,-0.02094878253568433
257,2018-06-08,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",GSK,0.007120141710261763,0.22573549628814948,0.001721151649111352,0.0046951439344171675,-0.005651227004966786,-0.001226999662743422,0.005676331831081294,0.0041442462922696155,-0.10391431135038132
258,2018-06-14,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",GSK,0.019445653207912583,0.9106023439629327,-0.0014561542525709514,0.0002428487017527292,0.0041442462922696155,0.007120141710261763,0.001721151649111352,-0.011921506999137965,-0.3048216833095577
259,2018-07-18,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Cocktail Clears FDA Hurdle, Cara To Offer Shares",GSK,-0.004132274437033789,-0.07403628620857916,-0.0014561542525709514,-0.012937224837894057,-0.00023947602599394546,0.015815045832361152,-0.00796514313101826,-0.006834160746237772,0.03434895084794487
260,2018-07-23,"The Week Ahead: FANG Earnings Continue, Fox Vote On Disney Deal, More IPOs",GSK,-0.022211578689475764,-0.6849781947447502,0.02899951152864566,-0.006834160746237772,-0.004132274437033789,-0.0014561542525709514,-0.012937224837894057,0.006595190452864719,0.039785946952070717
261,2018-07-25,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",GSK,-0.016743634595560608,0.41857798165137616,0.006595190452864719,-0.022211578689475764,0.02899951152864566,-0.006834160746237772,-0.004132274437033789,-0.003948935941714415,-0.3043358242798273
262,2018-07-25,"Earnings Scheduled For July 25, 2018",GSK,-0.016743634595560608,0.41857798165137616,0.006595190452864719,-0.022211578689475764,0.02899951152864566,-0.006834160746237772,-0.004132274437033789,-0.003948935941714415,-0.3043358242798273
263,2018-09-04,"The Week Ahead: Mr. Dorsey Goes To Washington, Employment And Wage Data On Tap",GSK,-0.003950697307938622,-0.0669820948139902,-0.017943704510085534,-0.008415398736603907,0.005317798802147333,-0.0028923217928933376,0.0050874576352417655,-0.005205768562637547,-0.26076364721089784
264,2018-09-07,Benzinga Pro's 5 Stocks To Watch Today,GSK,-0.004524918523909904,-0.2076042936342547,-0.008721506242353239,-0.005205768562637547,-0.003950697307938622,-0.017943704510085534,-0.008415398736603907,-0.007575790783923786,-0.040341388378901444
265,2018-09-07,"The Daily Biotech Pulse: Amgen-AstraZeneca, Boston Scientific Opens Walle, Advaxis Offering",GSK,-0.004524918523909904,-0.2076042936342547,-0.008721506242353239,-0.005205768562637547,-0.003950697307938622,-0.017943704510085534,-0.008415398736603907,-0.007575790783923786,-0.040341388378901444
266,2018-11-27,GlaxoSmithKline and J&J's HIV Drug Juluca Received Approval In Japan,GSK,-0.003698346523426821,-0.23690702470983138,-0.002459461867478474,0.00370302796710531,-0.002953580105683584,-0.004898443547929565,0.012146764267861654,0.01930209268013683,1.2317027929408022
267,2018-12-19,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",GSK,0.008358282998530475,2.5015240434921067,0.0005392629570140084,-0.014357610493034079,-0.008698168913116255,0.006900420411073638,0.008564941673843363,0.013368900817863238,-0.5626892044642509
268,2019-01-08,"TD Ameritrade IMX Continued Its Dip In December, Falling To A More Than Two-Year Low",GSK,0.006441689975373421,-0.08485632015043776,0.004919914292497829,0.02088235798242799,-0.001319546605870081,-0.008636582941403681,0.0015727294538314673,0.003584207185953092,-0.28022860078340717
269,2019-02-06,"13 Stocks To Watch For February 6, 2019",GSK,0.031178779320959915,0.7914177587339317,0.007920326745816109,-0.0015305428644597496,0.0,0.012658117990424822,-0.0002581718520477949,-0.0027042741692554495,-0.3585208722523875
270,2019-02-06,A Peek Into The Markets: US Stock Futures Down Ahead Of General Motors Earnings,GSK,0.031178779320959915,0.7914177587339317,0.007920326745816109,-0.0015305428644597496,0.0,0.012658117990424822,-0.0002581718520477949,-0.0027042741692554495,-0.3585208722523875
271,2019-02-15,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",GSK,0.00930016422336366,0.0928658868335146,0.01213785660904243,-0.0039480158018013745,0.007457250365364265,-0.020929483162554496,0.012817274418506663,0.001212265115088762,-0.16727340614207042
272,2019-03-29,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,GSK,-0.0019107353886973488,-0.3144174447601925,0.0033546713215550916,0.003125152714927637,0.009463848948794595,-0.000969839332682243,0.0002423220788314584,0.000478709134224653,-0.011885124561180849
273,2019-07-24,"Earnings Scheduled For July 24, 2019",GSK,0.0026621940773237096,0.12057420105056327,0.0046195166657383435,0.004150359225173927,-0.010867141746369047,0.006563167696298722,-0.000971664271005257,0.0026550152403437277,0.12810420095899233
274,2019-07-29,New Equities that Broke Through 52-Week Highs Monday Morning,GSK,0.00644214681342814,0.06981990176459885,0.008907308312551931,0.0026550152403437277,0.0026621940773237096,0.0046195166657383435,0.004150359225173927,-0.008534728962754423,-0.19109644946265814
275,2019-08-22,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",GSK,0.007127007515626227,0.13836282727931293,0.010680562030596974,-0.0027248725298494314,0.004478822186406273,0.005755785198200636,0.0070565278692977795,0.005124395715337071,0.5343181818181819
276,2019-08-28,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,GSK,0.0012119812376276684,0.10759613563174852,-0.0007264196358179875,0.0024277529221163885,0.005124395715337071,0.007127007515626227,0.010680562030596974,0.009924749399940813,0.49911635596602255
277,2019-09-25,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",GSK,-0.01568815388574618,-0.18486899047918792,0.003578267401242119,0.006966080764882143,0.007502343696067504,0.006332407056730327,-0.0009734035357096271,0.015213771036916013,0.42709590231188765
278,2019-09-27,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",GSK,0.007136106576639767,-0.19778138528138534,0.015213771036916013,-0.01568815388574618,0.003578267401242119,0.006966080764882143,0.007502343696067504,0.008030118791007457,0.5532883642495785
279,2019-09-30,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,GSK,0.008030118791007457,0.5532883642495785,0.007136106576639767,0.015213771036916013,-0.01568815388574618,0.003578267401242119,0.006966080764882143,-0.008669229019150237,-0.5065139507111063
280,2019-09-30,Stocks That Hit 52-Week Highs On Monday,GSK,0.008030118791007457,0.5532883642495785,0.007136106576639767,0.015213771036916013,-0.01568815388574618,0.003578267401242119,0.006966080764882143,-0.008669229019150237,-0.5065139507111063
281,2019-10-01,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",GSK,-0.008669229019150237,-0.5065139507111063,0.008030118791007457,0.007136106576639767,0.015213771036916013,-0.01568815388574618,0.003578267401242119,-0.0264712497228744,0.6258937410625893
282,2019-10-30,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,GSK,0.023548138518509676,0.9241698695734357,0.004278946548548657,0.013236286898937744,-0.004543453429217248,0.017332822111527202,0.017638872498519476,0.0035057059588878836,-0.32087365129263057
283,2019-10-30,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",GSK,0.023548138518509676,0.9241698695734357,0.004278946548548657,0.013236286898937744,-0.004543453429217248,0.017332822111527202,0.017638872498519476,0.0035057059588878836,-0.32087365129263057
284,2019-11-01,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",GSK,-0.01157202098088872,-0.33045637551532103,0.0035057059588878836,0.023548138518509676,0.004278946548548657,0.013236286898937744,-0.004543453429217248,-0.005301537886358898,0.006157280714388591
285,2019-12-10,Stocks That Hit 52-Week Highs On Tuesday,GSK,0.01139614399677824,-0.3705734966592428,0.0026369502743150974,0.006635575971495111,0.003106127973543815,0.009406538334212122,-0.006231911906787957,0.0030332446872927132,-0.06846830908045465
286,2019-12-11,Stocks That Hit 52-Week Highs On Wednesday,GSK,0.0030332446872927132,-0.06846830908045465,0.01139614399677824,0.0026369502743150974,0.006635575971495111,0.003106127973543815,0.009406538334212122,-0.007776874895141672,0.1639048478229903
287,2019-12-11,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",GSK,0.0030332446872927132,-0.06846830908045465,0.01139614399677824,0.0026369502743150974,0.006635575971495111,0.003106127973543815,0.009406538334212122,-0.007776874895141672,0.1639048478229903
288,2019-12-12,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",GSK,-0.007776874895141672,0.1639048478229903,0.0030332446872927132,0.01139614399677824,0.0026369502743150974,0.006635575971495111,0.003106127973543815,0.0010886089528376885,-0.0217843593195447
289,2019-12-16,Stocks That Hit 52-Week Highs On Tuesday,GSK,0.019573653097076038,0.6132032194837149,0.0010886089528376885,-0.007776874895141672,0.0030332446872927132,0.01139614399677824,0.0026369502743150974,-0.005119396636408147,-0.4487242457927255
290,2019-12-17,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",GSK,-0.005119396636408147,-0.4487242457927255,0.019573653097076038,0.0010886089528376885,-0.007776874895141672,0.0030332446872927132,0.01139614399677824,0.00514573971901755,0.11052754982415003
291,2019-12-20,Stocks That Hit 52-Week Highs On Friday,GSK,0.006594354962043969,0.48347016967706624,0.002773046249864075,0.00514573971901755,-0.005119396636408147,0.019573653097076038,0.0010886089528376885,-0.009932413554478603,-0.2136663837951518
292,2019-12-27,Stocks That Hit 52-Week Highs On Friday,GSK,0.008100798242153484,0.8020383485921576,0.00021306627247663634,0.001067327320391831,-0.009932413554478603,0.006594354962043969,0.002773046249864075,-0.004440705906690101,-0.2356690950920245
293,2020-01-15,Stocks That Hit 52-Week Highs On Wednesday,GSK,0.012117091073126307,0.2426882389545737,0.00191698274344132,0.0034195593712467165,0.003000829708808439,0.0051716269758119715,0.004328051437360703,-0.009451573936626323,0.40497109300314116
294,2020-01-17,Stocks That Hit 52-Week Highs On Friday,GSK,0.015479274157017553,0.06493211936623133,-0.009451573936626323,0.012117091073126307,0.00191698274344132,0.0034195593712467165,0.003000829708808439,-0.008143593587187303,0.10213892354032916
295,2020-01-24,Stocks That Hit 52-Week Highs On Friday,GSK,-0.012337850607841983,1.0988914994879209,0.0006276691610020979,0.006105107243183472,-0.008143593587187303,0.015479274157017553,-0.009451573936626323,-0.015879866354926664,-0.4857561101623158
296,2020-02-05,"Earnings Scheduled For February 5, 2020",GSK,-0.04350595949236069,2.7289151965335807,0.008345840900303658,-0.0014955107450068672,-0.0038316119741276244,-0.004450115717788972,0.008333550676309143,-0.02063470522388211,-0.2963116667531255
297,2020-02-27,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",GSK,-0.007398549483133898,0.8049844648641502,0.01012541912856979,-0.01049616784948626,-0.026926555434912514,0.007483732585358727,-0.0030542790697530853,-0.02548694784172756,1.0340792557866978
298,2020-03-02,How The COVID-19 Outbreak Is Benefiting Biotech Investors,GSK,0.049839565001550845,-0.04277213104423061,-0.02548694784172756,-0.007398549483133898,0.01012541912856979,-0.01049616784948626,-0.026926555434912514,-0.029377252730842685,-0.20062825649417826
299,2020-03-03,Pfizer Works On Compounds That May Help Stop Coronaviruses,GSK,-0.029377252730842685,-0.20062825649417826,0.049839565001550845,-0.02548694784172756,-0.007398549483133898,0.01012541912856979,-0.01049616784948626,0.049636800254873936,-0.3905687460291315
300,2020-03-10,How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?,GSK,0.00736746048393111,0.246727160355096,-0.03916940819506731,-0.004930866305771109,-0.01753160174076074,0.049636800254873936,-0.029377252730842685,-0.02803509562871931,-0.001306939170995003
301,2020-03-12,Stocks That Hit 52-Week Lows On Thursday,GSK,-0.08427414828418156,0.15554878667885075,-0.02803509562871931,0.00736746048393111,-0.03916940819506731,-0.004930866305771109,-0.01753160174076074,0.03670226815623434,-0.1533452440226889
302,2020-03-13,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",GSK,0.03670226815623434,-0.1533452440226889,-0.08427414828418156,-0.02803509562871931,0.00736746048393111,-0.03916940819506731,-0.004930866305771109,-0.1104357423552399,0.0875095131569843
303,2020-03-16,8 Biotechs With Coronavirus Vaccines In Development,GSK,-0.1104357423552399,0.0875095131569843,0.03670226815623434,-0.08427414828418156,-0.02803509562871931,0.00736746048393111,-0.03916940819506731,0.09444590903072636,-0.3293677301693334
304,2020-03-16,Stocks That Hit 52-Week Lows On Monday,GSK,-0.1104357423552399,0.0875095131569843,0.03670226815623434,-0.08427414828418156,-0.02803509562871931,0.00736746048393111,-0.03916940819506731,0.09444590903072636,-0.3293677301693334
305,2020-03-17,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",GSK,0.09444590903072636,-0.3293677301693334,-0.1104357423552399,0.03670226815623434,-0.08427414828418156,-0.02803509562871931,0.00736746048393111,-0.06974197930263049,0.19466228181128264
306,2020-03-19,Stocks That Hit 52-Week Lows On Thursday,GSK,-0.01808636806244268,0.1990868184224457,-0.06974197930263049,0.09444590903072636,-0.1104357423552399,0.03670226815623434,-0.08427414828418156,-0.009506896746191984,-0.22591967153405512
307,2020-03-23,Stocks That Hit 52-Week Lows On Monday,GSK,-0.04469102731493435,0.09403427724071056,-0.009506896746191984,-0.01808636806244268,-0.06974197930263049,0.09444590903072636,-0.1104357423552399,0.06750378837514481,-0.06754942720483781
308,2020-03-24,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",GSK,0.06750378837514481,-0.06754942720483781,-0.04469102731493435,-0.009506896746191984,-0.01808636806244268,-0.06974197930263049,0.09444590903072636,0.04176472884518834,-0.014494171581919346
309,2020-04-14,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",GSK,0.0369801372078129,1.4499917067507049,0.001542861938580442,0.02100845396083728,0.014655127544009883,-0.010023731601553343,0.02073272806926929,-0.013868112176230407,-0.44377496445738274
310,2020-04-20,How The COVID-19 Pandemic Could End,GSK,-0.008319410700547758,-0.3161630794701987,0.006459352452870215,0.049723510963941564,-0.013868112176230407,0.0369801372078129,0.001542861938580442,-0.012464162454660754,0.0801380019973974
311,2020-04-24,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",GSK,0.006870464971315382,0.015139858218387703,0.007158056654007705,0.01723312538522692,-0.012464162454660754,-0.008319410700547758,0.006459352452870215,0.0030589301868153562,-0.2895385031804033
312,2020-04-30,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",GSK,0.005256915367698012,-0.2102681713935376,-0.005702144582140245,-0.012667178329757944,0.0030589301868153562,0.006870464971315382,0.007158056654007705,-0.020442163252215262,-0.06460795307513156
313,2020-06-08,4 Analysts On Why The Rumored AstraZeneca-Gilead Deal Is Unlikely To Materialize,GSK,0.016067324562068608,0.9246851385390429,0.0012004966575915876,-0.011158602505107806,0.002141377833818847,0.004300967259152522,-0.0016699323954609824,-0.011564860469010507,-0.45083852150989956
314,2020-06-16,"The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO",GSK,0.014734543577518577,0.0563918700731314,0.0074222773834640154,0.005222522219253012,-0.05187444577704736,0.012655106717753384,-0.011564860469010507,0.012342733104016013,-0.34928412487918903
315,2020-06-17,"The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked",GSK,0.012342733104016013,-0.34928412487918903,0.014734543577518577,0.0074222773834640154,0.005222522219253012,-0.05187444577704736,0.012655106717753384,-0.021037443998196514,-0.3375012952920452
316,2020-06-23,"The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout",GSK,0.008976410540260327,0.07375681889905783,0.0029198116525726014,0.0036628402218532585,-0.021037443998196514,0.012342733104016013,0.014734543577518577,-0.022120956569323558,-0.032077927530755335
317,2020-07-14,"The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits",GSK,0.015722526090937272,0.15123005724028737,0.004008943582723745,-0.011394411095583812,-0.008838899293870939,0.008667666830528775,-0.015361935050026143,0.030712412906316988,0.29610430827008005
318,2020-07-15,"The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent",GSK,0.030712412906316988,0.29610430827008005,0.015722526090937272,0.004008943582723745,-0.011394411095583812,-0.008838899293870939,0.008667666830528775,-0.010965148907851052,-0.4394678311261656
319,2020-07-29,"Earnings Scheduled For July 29, 2020",GSK,-0.017191283344110353,0.2210132689987938,0.010274069777141737,0.014643726963589287,-0.0002481206725639673,-0.021131715739105328,-0.00962235051510052,-0.00837647466317315,-0.29523226176127715
320,2020-07-29,"The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More",GSK,-0.017191283344110353,0.2210132689987938,0.010274069777141737,0.014643726963589287,-0.0002481206725639673,-0.021131715739105328,-0.00962235051510052,-0.00837647466317315,-0.29523226176127715
321,2020-07-29,"GlaxoSmithKline, Sanofi Ink Deal With UK To Supply Up To 60M Doses of COVID-19 Vaccine",GSK,-0.017191283344110353,0.2210132689987938,0.010274069777141737,0.014643726963589287,-0.0002481206725639673,-0.021131715739105328,-0.00962235051510052,-0.00837647466317315,-0.29523226176127715
322,2020-07-31,"The Daily Biotech Pulse: Sanofi-GSK Land $2.1M Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche",GSK,0.0017388939659295222,0.4680815273767136,-0.00837647466317315,-0.017191283344110353,0.010274069777141737,0.014643726963589287,-0.0002481206725639673,0.0240578279060637,-0.43851809414685383
323,2020-08-05,"J&J Clinches Coronavirus Vaccine Deal With US Government: $1B, 100M Doses",GSK,-0.0007277126886255925,0.07956674740642566,-0.0012109633051503588,0.0240578279060637,0.0017388939659295222,-0.00837647466317315,-0.017191283344110353,-0.005823613114166348,0.22622978579290498
324,2020-08-06,GlaxoSmithKline Gets FDA Approval For Blood Cancer Drug,GSK,-0.005823613114166348,0.22622978579290498,-0.0007277126886255925,-0.0012109633051503588,0.0240578279060637,0.0017388939659295222,-0.00837647466317315,-0.004393560779950123,0.01784851204860871
325,2020-08-06,Moderna Analyst Breaks Down Biopharma's Coronavirus Vaccine Pricing,GSK,-0.005823613114166348,0.22622978579290498,-0.0007277126886255925,-0.0012109633051503588,0.0240578279060637,0.0017388939659295222,-0.00837647466317315,-0.004393560779950123,0.01784851204860871
326,2020-08-26,"AstraZeneca, Novavax, Pfizer, Others Lobby EU For Legal Protection Against COVID-19 Vaccine Liabilities: FT",GSK,0.0017438608656512589,-0.11460132977331028,-0.002485100056820344,0.0007461291535524328,-0.009361993838803984,-0.0036817952248167085,-0.008517924016807399,-0.011440075356793589,0.4790089877010406
327,2020-09-01,"Sanofi, Regeneron Rheumatoid Arthritis Drug Proves Ineffective Against COVID-19",GSK,-0.01616149061292438,0.722686345493363,0.0,-0.003773493253750426,-0.011440075356793589,0.0017438608656512589,-0.002485100056820344,0.024127212894662575,-0.23412452515020077
328,2020-09-03,A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Economic Reports,GSK,-0.022305774373760356,-0.02775530305695295,0.024127212894662575,-0.01616149061292438,0.0,-0.003773493253750426,-0.011440075356793589,-0.01384257602506489,0.3643534264418553
329,2020-09-03,"Be Ready To Distribute A COVID-19 Vaccine In Two Months, CDC Tells All States",GSK,-0.022305774373760356,-0.02775530305695295,0.024127212894662575,-0.01616149061292438,0.0,-0.003773493253750426,-0.011440075356793589,-0.01384257602506489,0.3643534264418553
330,2020-09-08,AstraZeneca Shares Drop 8% As Advanced COVID-19 Vaccine Trials Are Halted,GSK,0.012996972474422552,-0.19224037339556588,-0.01384257602506489,-0.022305774373760356,0.024127212894662575,-0.01616149061292438,0.0,0.020015419531930645,0.07488755376079315
331,2020-09-08,"As Political Pressure Mounts, COVID-19 Vaccine Developers Pledge To Put Safety First",GSK,0.012996972474422552,-0.19224037339556588,-0.01384257602506489,-0.022305774373760356,0.024127212894662575,-0.01616149061292438,0.0,0.020015419531930645,0.07488755376079315
332,2020-09-09,"The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment",GSK,0.020015419531930645,0.07488755376079315,0.012996972474422552,-0.01384257602506489,-0.022305774373760356,0.024127212894662575,-0.01616149061292438,-0.02465402416675111,-0.19761759315821625
333,2020-09-17,Is AstraZeneca Still A Safe Bet?,GSK,0.0012685067558755314,0.2501316230316375,0.00381961688590704,0.004861754907909743,-0.0007671146406049711,0.008769727913541248,-0.02465402416675111,-0.00532038901529619,0.4104291894789234
334,2020-09-30,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,GSK,0.005610358349937616,0.3038491039676452,-0.011357500632667161,0.0015872856605656516,0.011235957647237838,-0.010849567843244534,-0.005526316296882605,-0.013283683691936332,0.03829184159157162
335,2020-10-06,"COVID-19 Vaccine Makers AstraZeneca, GSK To Get First Access To Nvidia's 'Cambridge-1' Supercomputer",GSK,-0.023348397910208818,0.701838696197242,0.012083832346417855,0.002692526307311871,-0.013283683691936332,0.005610358349937616,-0.011357500632667161,-0.0059767323683760365,-0.07960712093308775
336,2020-10-28,"Earnings Scheduled For October 28, 2020",GSK,-0.03960394892799768,0.12275121160742408,0.0036911497760840906,-0.0019836465792019142,0.005699654236452467,-0.0073550286663233155,-0.01914549874667626,0.00029446321558390665,-0.12304217672529005
337,2020-10-28,"The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts",GSK,-0.03960394892799768,0.12275121160742408,0.0036911497760840906,-0.0019836465792019142,0.005699654236452467,-0.0073550286663233155,-0.01914549874667626,0.00029446321558390665,-0.12304217672529005
338,2020-12-11,A Peek Into The Markets: US Stock Futures Down; Pfizer Covid-19 Vaccine Gets FDA Panel's Nod,GSK,-0.010007902273167169,0.24180483668158015,0.0034355956271334698,0.005313503369059003,0.002129860177438214,0.0016001497906334983,0.006171094414730183,-0.020218145773378993,0.4274478406254416
339,2020-12-17,"The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut",GSK,0.01247282095732083,0.025601933089779427,0.0016295860712691734,-0.0002716394439883363,-0.020218145773378993,-0.010007902273167169,0.0034355956271334698,-0.00883779401714091,0.6386839817126189
340,2020-12-18,"The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data",GSK,-0.00883779401714091,0.6386839817126189,0.01247282095732083,0.0016295860712691734,-0.0002716394439883363,-0.020218145773378993,-0.010007902273167169,-0.021345378349142297,-0.2872278515678488
341,2020-12-21,GlaxoSmithKline's ViiV Healthcare Bags EU Marketing Authorization For Long-Acting HIV Treatment,GSK,-0.021345378349142297,-0.2872278515678488,-0.00883779401714091,0.01247282095732083,0.0016295860712691734,-0.0002716394439883363,-0.020218145773378993,-0.0035893757016970396,-0.07842854741493166
342,2021-01-12,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",GSK,-0.012391414270887413,0.5234359773923212,-0.01069359173645723,0.00709213595376923,-0.006524045096744091,0.016985184761048933,-0.0015900863046346414,0.005872950959342926,-0.3709022291873221
343,2021-01-22,"The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa",GSK,0.015351820772462554,0.2540191432023047,-0.006312497208852963,-0.013492339092792682,0.0018196409499964261,0.008123538176848966,0.012739029740364227,0.014598650269929347,-0.2746118789136315
344,2021-01-27,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",GSK,-0.027013216298547138,0.28187165076460596,0.008221851908261968,0.014598650269929347,0.015351820772462554,-0.006312497208852963,-0.013492339092792682,-0.003928624927776125,-0.24701252090215753
345,2021-02-03,"The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision",GSK,-0.05772834422243356,5.808690199357249,0.006695384834195517,0.0024160477940839975,-0.02051013959284076,-0.003928624927776125,-0.027013216298547138,-0.0011292711170365344,-0.5193273699196819
346,2021-02-11,Merck In Talks To Possibly Produce COVID-19 Shots: WSJ,GSK,-0.006190527163771886,0.4272906853061844,-0.005873783992444759,0.008177993970054809,0.005672339468768106,-0.0033918238522434585,-0.0011292711170365344,0.012740887496467623,-0.20545885233684658
347,2021-02-17,Shortage Of Giant Sterile Liners Threatens Global Vaccines Rollout: FT,GSK,0.00757332503179331,-0.07190010806747171,-0.0033546044617024373,0.012740887496467623,-0.006190527163771886,-0.005873783992444759,0.008177993970054809,-0.01677429994142876,-0.042221969092911094
348,2021-02-18,Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters,GSK,-0.01677429994142876,-0.042221969092911094,0.00757332503179331,-0.0033546044617024373,0.012740887496467623,-0.006190527163771886,-0.005873783992444759,-0.007780848676581575,-0.029058473736372603
349,2021-02-22,Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback,GSK,0.0002904124603764213,-0.06606238771843864,-0.007780848676581575,-0.01677429994142876,0.00757332503179331,-0.0033546044617024373,0.012740887496467623,-0.001742211672830396,0.16471394013581642
350,2021-02-23,FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants,GSK,-0.001742211672830396,0.16471394013581642,0.0002904124603764213,-0.007780848676581575,-0.01677429994142876,0.00757332503179331,-0.0033546044617024373,0.008726018134765479,-0.20026274632467944
351,2021-02-25,Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain,GSK,-0.008650533423238849,-0.04433736447691605,0.008726018134765479,-0.001742211672830396,0.0002904124603764213,-0.007780848676581575,-0.01677429994142876,-0.022396654213608813,0.2511418515183761
352,2021-02-25,Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses,GSK,-0.008650533423238849,-0.04433736447691605,0.008726018134765479,-0.001742211672830396,0.0002904124603764213,-0.007780848676581575,-0.01677429994142876,-0.022396654213608813,0.2511418515183761
353,2021-02-26,Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg,GSK,-0.022396654213608813,0.2511418515183761,-0.008650533423238849,0.008726018134765479,-0.001742211672830396,0.0002904124603764213,-0.007780848676581575,0.003570284554185621,-0.2838170256195536
354,2021-03-02,"Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report",GSK,0.01067299682283629,0.033689595322919486,0.003570284554185621,-0.022396654213608813,-0.008650533423238849,0.008726018134765479,-0.001742211672830396,0.004400185981046967,0.11532547411583804
355,2021-03-02,"People Allergic To Pfizer, Moderna COVID-19 Vaccine Might Be Allowed To Get JNJ Shot: CNBC",GSK,0.01067299682283629,0.033689595322919486,0.003570284554185621,-0.022396654213608813,-0.008650533423238849,0.008726018134765479,-0.001742211672830396,0.004400185981046967,0.11532547411583804
356,2021-03-02,European Officials Seek To Garner Support For AstraZeneca COVID-19 Shot: CNBC,GSK,0.01067299682283629,0.033689595322919486,0.003570284554185621,-0.022396654213608813,-0.008650533423238849,0.008726018134765479,-0.001742211672830396,0.004400185981046967,0.11532547411583804
357,2021-03-02,"AstraZeneca, Pfizer/BioNtech Single Shot COVID-19 Jab 80% Effective At Preventing Hospitalizations In Elderly",GSK,0.01067299682283629,0.033689595322919486,0.003570284554185621,-0.022396654213608813,-0.008650533423238849,0.008726018134765479,-0.001742211672830396,0.004400185981046967,0.11532547411583804
358,2021-03-02,Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May,GSK,0.01067299682283629,0.033689595322919486,0.003570284554185621,-0.022396654213608813,-0.008650533423238849,0.008726018134765479,-0.001742211672830396,0.004400185981046967,0.11532547411583804
359,2021-03-03,EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters,GSK,0.004400185981046967,0.11532547411583804,0.01067299682283629,0.003570284554185621,-0.022396654213608813,-0.008650533423238849,0.008726018134765479,0.00116815696786432,0.23093623225152138
360,2021-03-04,"Emergent BioSolutions Capable Of Manufacturing 1B COVID-19 Vaccine Doses Annually, CEO Says",GSK,0.00116815696786432,0.23093623225152138,0.004400185981046967,0.01067299682283629,0.003570284554185621,-0.022396654213608813,-0.008650533423238849,0.018378178946421464,-0.1698443554720187
361,2021-03-04,Novartis Lends Support To Manufacture CureVac's COVID-19 Shots,GSK,0.00116815696786432,0.23093623225152138,0.004400185981046967,0.01067299682283629,0.003570284554185621,-0.022396654213608813,-0.008650533423238849,0.018378178946421464,-0.1698443554720187
362,2021-03-05,"WHO, SII Warn Of Raw Materials Shortage For COVID-19 Shots, Cites US Law As 'Serious' Limit:' Bloomberg",GSK,0.018378178946421464,-0.1698443554720187,0.00116815696786432,0.004400185981046967,0.01067299682283629,0.003570284554185621,-0.022396654213608813,0.0017185162793458275,0.06803238012530244
363,2021-03-09,"Why AnPac Bio-Medical, Surface Oncology, CorMedix Are Rallying Today",GSK,0.0037176619039696046,-0.15711983273075747,0.0017185162793458275,0.018378178946421464,0.00116815696786432,0.004400185981046967,0.01067299682283629,0.01424487748073644,-0.18173987941429803
364,2021-03-09,Surface Oncology To Test SRF388 Plus Keytruda Combo In Solid Tumor Settings,GSK,0.0037176619039696046,-0.15711983273075747,0.0017185162793458275,0.018378178946421464,0.00116815696786432,0.004400185981046967,0.01067299682283629,0.01424487748073644,-0.18173987941429803
365,2021-03-10,"Pfizer, BioNTech Predict Increase In Capacity To 3B COVID-19 Vaccine Shots In 2022: Bloomberg",GSK,0.01424487748073644,-0.18173987941429803,0.0037176619039696046,0.0017185162793458275,0.018378178946421464,0.00116815696786432,0.004400185981046967,-0.0014045163203527666,0.02564210526315791
366,2021-03-15,"Germany, France Join List Of Countries Suspending AZN's COVID-19 Vaccine; WHO Urges Not To Halt Vaccinations",GSK,0.009566575395646648,0.02592157063244538,-0.0002812042646137547,-0.0014045163203527666,0.01424487748073644,0.0037176619039696046,0.0017185162793458275,0.013099238327761054,-0.15542044586198878
367,2021-03-17,"Pfizer/BioNTech COVID-19 Vaccination Could Protect Pregnant Women, Newborns, Study In Israel Suggests: Reuters",GSK,0.0,0.2077416309350537,0.013099238327761054,0.009566575395646648,-0.0002812042646137547,-0.0014045163203527666,0.01424487748073644,0.003576351063720784,-0.2252133411504137
368,2021-03-18,"The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq",GSK,0.003576351063720784,-0.2252133411504137,0.0,0.013099238327761054,0.009566575395646648,-0.0002812042646137547,-0.0014045163203527666,0.004112020996773769,-0.21910667367314762
369,2021-03-22,AstraZeneca's COVID-19 Shot Shows 79% Efficacy In US Trials,GSK,0.0010918809984399314,-0.13926946784743344,0.004112020996773769,0.003576351063720784,0.0,0.013099238327761054,0.009566575395646648,-0.018543669904227733,0.6768927666760485
370,2021-03-23,"Mastercard, SoftBank And Leading Companies Seek G7 To Create Global Tech Body: FT",GSK,-0.018543669904227733,0.6768927666760485,0.0010918809984399314,0.004112020996773769,0.003576351063720784,0.0,0.013099238327761054,-0.003334357579703906,0.09348774756629741
371,2021-03-29,White House Contemplates Waiving-Off Patent Protections For COVID-19 Treatments,GSK,0.0005452310299620677,-0.1324026120243188,0.01663446769459953,0.005575543698268293,-0.003334357579703906,-0.018543669904227733,0.0010918809984399314,-0.008721449656402203,0.16441733713989093
372,2021-03-29,Glaxo To Fill About 60M Novavax COVID-19 Shots For Britain,GSK,0.0005452310299620677,-0.1324026120243188,0.01663446769459953,0.005575543698268293,-0.003334357579703906,-0.018543669904227733,0.0010918809984399314,-0.008721449656402203,0.16441733713989093
373,2021-03-30,"The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings",GSK,-0.008721449656402203,0.16441733713989093,0.0005452310299620677,0.01663446769459953,0.005575543698268293,-0.003334357579703906,-0.018543669904227733,-0.01869697138998505,0.7179594338571269
374,2021-03-31,EMA May Issue Updated Recommendation If AstraZeneca Jab-Clot Link Is Established: Report,GSK,-0.01869697138998505,0.7179594338571269,-0.008721449656402203,0.0005452310299620677,0.01663446769459953,0.005575543698268293,-0.003334357579703906,0.003642604437571695,0.2765767665136796
375,2021-03-31,Pfizer-BioNTech's COVID-19 Vaccine Gives 100% Protection In Adolescents,GSK,-0.01869697138998505,0.7179594338571269,-0.008721449656402203,0.0005452310299620677,0.01663446769459953,0.005575543698268293,-0.003334357579703906,0.003642604437571695,0.2765767665136796
376,2021-04-07,Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots,GSK,0.0011106043798068121,-0.5451711513599071,-0.0016631359406202861,0.007258651331447208,0.003642604437571695,-0.01869697138998505,-0.008721449656402203,0.011092563599625516,0.13184390192067585
377,2021-04-08,"Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC",GSK,0.011092563599625516,0.13184390192067585,0.0011106043798068121,-0.0016631359406202861,0.007258651331447208,0.003642604437571695,-0.01869697138998505,0.005211248563277149,-0.10728535886964274
378,2021-04-12,"South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Reports",GSK,-0.016098225252632048,0.9159458393584856,0.005211248563277149,0.011092563599625516,0.0011106043798068121,-0.0016631359406202861,0.007258651331447208,-0.0005545702069301717,-0.5471299383859591
379,2021-04-14,"UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots",GSK,0.0024971246812903747,0.2968607963153749,-0.0005545702069301717,-0.016098225252632048,0.005211248563277149,0.011092563599625516,0.0011106043798068121,0.043177415242993566,3.7130540433187695
380,2021-04-23,"The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs",GSK,0.001592625786423385,-0.03946244076749783,-0.01490223418193204,0.014588975025468631,-0.007372261849654005,0.006092766076591261,0.001591870213434765,0.0010596560311100234,-0.2759603720177921
381,2021-04-23,Oscar Telecast Sells Out Advertising Slots Despite Historically Low Award Show Ratings,GSK,0.001592625786423385,-0.03946244076749783,-0.01490223418193204,0.014588975025468631,-0.007372261849654005,0.006092766076591261,0.001591870213434765,0.0010596560311100234,-0.2759603720177921
382,2021-04-26,Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine,GSK,0.0010596560311100234,-0.2759603720177921,0.001592625786423385,-0.01490223418193204,0.014588975025468631,-0.007372261849654005,0.006092766076591261,-0.0013233616040763119,-0.030744743235318728
383,2021-04-27,US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses,GSK,-0.0013233616040763119,-0.030744743235318728,0.0010596560311100234,0.001592625786423385,-0.01490223418193204,0.014588975025468631,-0.007372261849654005,-0.000795091289223615,-0.15678478824546238
384,2021-04-28,Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran,GSK,-0.000795091289223615,-0.15678478824546238,-0.0013233616040763119,0.0010596560311100234,0.001592625786423385,-0.01490223418193204,0.014588975025468631,-0.005305122155550235,0.03075030750307506
385,2021-04-29,Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters,GSK,-0.005305122155550235,0.03075030750307506,-0.000795091289223615,-0.0013233616040763119,0.0010596560311100234,0.001592625786423385,-0.01490223418193204,-0.004266644070593406,0.12360779634049335
386,2021-04-30,"Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days",GSK,-0.004266644070593406,0.12360779634049335,-0.005305122155550235,-0.000795091289223615,-0.0013233616040763119,0.0010596560311100234,0.001592625786423385,0.008837688540453303,0.2020827801870373
387,2021-05-03,Novavax Next In List To Start Testing Its COVID-19 Shot In Adolescents,GSK,0.008837688540453303,0.2020827801870373,-0.004266644070593406,-0.005305122155550235,-0.000795091289223615,-0.0013233616040763119,0.0010596560311100234,-0.004512878797128028,0.845191057010332
388,2021-05-06,"Biden Administration Backs Waiving IP Protections For COVID-19 Vaccines, Pharma Industry Rebukes Move",GSK,0.003440762304092404,0.31644926308656607,0.007466627123538405,-0.004512878797128028,0.008837688540453303,-0.004266644070593406,-0.005305122155550235,0.011606598310167415,-0.033586411015313344
389,2021-05-07,"The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs",GSK,0.011606598310167415,-0.033586411015313344,0.003440762304092404,0.007466627123538405,-0.004512878797128028,0.008837688540453303,-0.004266644070593406,0.004693641550436833,0.13551930758988018
390,2021-05-10,FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children,GSK,0.004693641550436833,0.13551930758988018,0.011606598310167415,0.003440762304092404,0.007466627123538405,-0.004512878797128028,0.008837688540453303,-0.008824300813600083,0.3072322711148896
391,2021-05-26,FDA May Not Review New COVID-19 Vaccine Emergency Use Requests,GSK,0.0012934794148133921,-0.035616998093162655,-0.00025867163316206643,-0.004633031146506372,-0.004611875553128142,0.007927953147900624,-0.007836235208174669,-0.0056834032392499845,1.2251253442553494
392,2021-05-27,"The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-term Migraine Drug Data, Decision Day For Eton, 2 IPOs",GSK,-0.0056834032392499845,1.2251253442553494,0.0012934794148133921,-0.00025867163316206643,-0.004633031146506372,-0.004611875553128142,0.007927953147900624,0.00727464109048559,-0.38533798794033636
393,2021-06-01,"CureVac's COVID-19 Vaccine Is Safe, But Efficacy Not Yet Disclosed",GSK,-0.010832994735751833,-0.23773750516315573,0.00727464109048559,-0.0056834032392499845,0.0012934794148133921,-0.00025867163316206643,-0.004633031146506372,0.0010428898115280028,-0.00728147119585465
394,2021-06-14,"IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings",GSK,0.008468175252372756,0.06005985106827194,-0.001988411170988913,0.01719349877280929,0.01880464574864904,0.0018063242318464567,-0.00385586081193956,0.001975744612443764,-0.2030921743697479
395,2021-07-07,"COVID-19 Vaccine-Induced Blood Clots Probably Linked To Amino Acids, Study Shows: WSJ",GSK,0.004493296814184866,0.5581479192418624,-0.008661225147246765,0.005974760295923476,0.008789452574040624,-0.003253957019270004,0.001755142290747802,-0.006709796115766387,0.010577463392060338
396,2021-07-28,"Earnings Scheduled For July 28, 2021",GSK,-0.0005062161252693542,0.07804748832057018,0.012814082011943118,-0.012401886649443306,0.007137312942572915,-0.002288930144671797,0.005883941366988665,0.015189789347118232,0.2036768155114259
397,2021-08-02,GlaxoSmithKline Files US Application For Approval Of Its MMR Vaccine,GSK,0.0024913695071746567,0.3614066925128543,0.0009975830880351033,0.015189789347118232,-0.0005062161252693542,0.012814082011943118,-0.012401886649443306,0.009940302014117774,-0.2830367782198614
398,2021-08-12,Do mRNA COVID-19 Vaccines Cause Skin Or Kidney Disorders? EMA Investigates Possible Links,GSK,0.003648777406216386,-0.42416864778162866,0.011315968253146735,0.001724967764855423,0.004206947864122235,-0.012463144974909524,0.010370149320617195,0.01720792460688436,0.060734182252287994
399,2021-08-17,Stocks That Hit 52-Week Highs On Tuesday,GSK,0.005940982081871882,0.1883331243993147,0.0026210723841144645,0.01720792460688436,0.003648777406216386,0.011315968253146735,0.001724967764855423,-0.004252338137961553,0.4352978409170827
400,2021-08-17,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",GSK,0.005940982081871882,0.1883331243993147,0.0026210723841144645,0.01720792460688436,0.003648777406216386,0.011315968253146735,0.001724967764855423,-0.004252338137961553,0.4352978409170827
401,2021-08-18,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",GSK,-0.004252338137961553,0.4352978409170827,0.005940982081871882,0.0026210723841144645,0.01720792460688436,0.003648777406216386,0.011315968253146735,0.004565159929347695,-0.2956611215914937
402,2021-08-19,"The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck",GSK,0.004565159929347695,-0.2956611215914937,-0.004252338137961553,0.005940982081871882,0.0026210723841144645,0.01720792460688436,0.003648777406216386,0.0009567341085792158,-0.3291940589237886
403,2021-08-24,Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial,GSK,-0.01108695729001452,-0.4023134585559194,-0.008602182141793202,0.0009567341085792158,0.004565159929347695,-0.004252338137961553,0.005940982081871882,0.0019496455397489676,-0.07251234367679393
404,2021-08-26,EU Says Without EMA Approval COVID-19 Boosters May Face Higher Legal Risks: Reuters,GSK,-0.003892000864734957,-0.24624052846318245,0.0019496455397489676,-0.01108695729001452,-0.008602182141793202,0.0009567341085792158,0.004565159929347695,-0.0031745627578642077,1.3591091865140736
405,2021-09-02,Can Vaccine Help In Long Term COVID-19 Symptoms? UK Study Gives Encouraging Answer,GSK,0.007783902653511809,-0.2868975903614458,0.009081897639822367,-0.004155448293700514,0.0022048348115049077,-0.0031745627578642077,-0.003892000864734957,0.004344743832255915,0.32902147131291803
406,2021-09-03,White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report,GSK,0.004344743832255915,0.32902147131291803,0.007783902653511809,0.009081897639822367,-0.004155448293700514,0.0022048348115049077,-0.0031745627578642077,-0.016101859578456446,-0.05114877838839971
407,2021-09-28,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",GSK,-0.011688171822325177,0.20936726758571944,0.0028652194652438734,-0.024148389358482847,0.0015274834515712765,0.0051176337673988215,0.005920389315055452,0.0073588254310115175,0.10080963376494312
408,2021-09-30,"GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact",GSK,-0.0031307892717310493,-0.2919122723169242,0.0073588254310115175,-0.011688171822325177,0.0028652194652438734,-0.024148389358482847,0.0015274834515712765,-0.0020936413359267103,1.1326308684565771
409,2021-09-30,"The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug",GSK,-0.0031307892717310493,-0.2919122723169242,0.0073588254310115175,-0.011688171822325177,0.0028652194652438734,-0.024148389358482847,0.0015274834515712765,-0.0020936413359267103,1.1326308684565771
410,2021-10-04,Tesla and Merck Give Investors Some Hope,GSK,0.007343171941785354,-0.22631125490127124,-0.0020936413359267103,-0.0031307892717310493,0.0073588254310115175,-0.011688171822325177,0.0028652194652438734,-0.004946573653663022,-0.4612290350438616
411,2021-10-12,Winners and Losers of Rising Energy Prices,GSK,0.010460206703236441,1.1214067451335445,-0.0121415951960554,0.001293439584244993,0.013899728059945105,-0.002354716968263504,-0.004946573653663022,0.0041407904595378575,-0.31200736206137714
412,2021-10-12,"The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology",GSK,0.010460206703236441,1.1214067451335445,-0.0121415951960554,0.001293439584244993,0.013899728059945105,-0.002354716968263504,-0.004946573653663022,0.0041407904595378575,-0.31200736206137714
413,2021-10-26,"The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children",GSK,0.009294058354667012,0.14565483476132202,0.0010060146835335626,0.005562571618856316,0.0022807218005562735,0.0074037957321020365,0.01345379613147113,0.005973075342108114,0.5358611514271892
414,2021-10-27,"Earnings Scheduled For October 27, 2021",GSK,0.005973075342108114,0.5358611514271892,0.009294058354667012,0.0010060146835335626,0.005562571618856316,0.0022807218005562735,0.0074037957321020365,0.04205833637902345,0.18821120604795838
415,2021-10-28,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",GSK,0.04205833637902345,0.18821120604795838,0.005973075342108114,0.009294058354667012,0.0010060146835335626,0.005562571618856316,0.0022807218005562735,0.004985765730221914,-0.42346820426152365
416,2021-11-29,3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries,GSK,0.008288530378070869,0.5349118316268486,-0.013942131995109408,0.0,0.007507784295083475,-0.0072132577223895655,0.0021685148319823266,-0.0058027350220513085,-0.08051141890952884
417,2021-12-02,"The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance",GSK,0.0024172703845966037,0.17228598450959853,0.006079819546447762,-0.0058027350220513085,0.008288530378070869,-0.013942131995109408,0.0,-0.005305112608622986,-0.10900329255794683
418,2021-12-02,Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant,GSK,0.0024172703845966037,0.17228598450959853,0.006079819546447762,-0.0058027350220513085,0.008288530378070869,-0.013942131995109408,0.0,-0.005305112608622986,-0.10900329255794683
419,2021-12-07,"The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Dar",GSK,0.014846763780046457,0.7791167253578006,0.012363669557956314,-0.005305112608622986,0.0024172703845966037,0.006079819546447762,-0.0058027350220513085,0.007078795887061284,-0.35297535818700176
420,2021-12-07,"Cramer Gives His Opinion On GlaxoSmithKline, Asana And More",GSK,0.014846763780046457,0.7791167253578006,0.012363669557956314,-0.005305112608622986,0.0024172703845966037,0.006079819546447762,-0.0058027350220513085,0.007078795887061284,-0.35297535818700176
421,2021-12-15,"Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back",GSK,0.017715604512792194,0.6823281406316992,-0.004871211967802602,-0.0013898139145962496,0.008644829133220844,0.002811634354252579,0.007078795887061284,0.003664606202952614,0.2543060422639907
422,2021-12-15,"The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO",GSK,0.017715604512792194,0.6823281406316992,-0.004871211967802602,-0.0013898139145962496,0.008644829133220844,0.002811634354252579,0.007078795887061284,0.003664606202952614,0.2543060422639907
423,2021-12-21,"The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail",GSK,0.006967102342961828,-0.0343632054770473,-0.00092817187383476,-0.01643083786228805,0.003664606202952614,0.017715604512792194,-0.004871211967802602,0.009455693837223889,-0.2874608007998909
424,2022-02-09,"Earnings Scheduled For February 9, 2022",GSK,-0.02122955275160998,-0.4361938187988572,0.005112158363436814,0.004241158199870254,-0.00267142805199172,-0.017067867060639785,0.011285711907528695,0.00406685076249258,0.9530289389067523
425,2022-02-10,Why Are Seagen Shares Sinking Today?,GSK,0.00406685076249258,0.9530289389067523,-0.02122955275160998,0.005112158363436814,0.004241158199870254,-0.00267142805199172,-0.017067867060639785,-0.003150284313159224,-0.5850982561508877
426,2022-02-25,Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption,GSK,0.036173844607330086,-0.31788265385695125,-0.030777986295663418,0.010072734438116182,-0.008131984897488675,-0.006463649516818881,-0.0016131665692993291,-0.019212762951084983,0.26543351015181993
427,2022-03-02,36 Stocks To Watch After Biden's First State of The Union Address,GSK,0.011552275811026247,-0.0517037768664248,-0.007405665287532837,-0.019212762951084983,0.036173844607330086,-0.030777986295663418,0.010072734438116182,-0.013799579414795704,0.7011434393750708
428,2022-03-16,"WHO Foundation Warns Global Economy To Lose ""Trillions Of Dollars"" On COVID-19 Vaccine Inequality: CNBC",GSK,0.009592251350378111,0.1451071276545428,0.022810977020487178,0.005177366570613184,-0.006612858493490248,-0.01233661374257744,0.03401708187905039,0.022565381847620358,-0.059002106480525396
429,2022-03-21,Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC,GSK,-0.0041841779291733605,0.13457432772806865,-0.0006967389577466898,0.022565381847620358,0.009592251350378111,0.022810977020487178,0.005177366570613184,0.009103579431326558,0.21181047423726662
430,2022-03-24,Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC,GSK,0.009088728431803084,0.09668266367744427,-0.007402191096991251,0.009103579431326558,-0.0041841779291733605,-0.0006967389577466898,0.022565381847620358,-0.00046187185564983135,2.0708467754815216
431,2022-03-28,FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant,GSK,0.0020794753701400825,-0.6864019804657839,-0.00046187185564983135,0.009088728431803084,-0.007402191096991251,0.009103579431326558,-0.0041841779291733605,-0.001844414094779423,0.5572987495439319
432,2022-03-29,FDA Approves ViiV Healthcare's Cabenuva For Virologically Suppressed Adolescents With HIV,GSK,-0.001844414094779423,0.5572987495439319,0.0020794753701400825,-0.00046187185564983135,0.009088728431803084,-0.007402191096991251,0.009103579431326558,0.009470833167708692,0.09780409362952858
433,2022-03-29,Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness,GSK,-0.001844414094779423,0.5572987495439319,0.0020794753701400825,-0.00046187185564983135,0.009088728431803084,-0.007402191096991251,0.009103579431326558,0.009470833167708692,0.09780409362952858
434,2022-03-30,"Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ",GSK,0.009470833167708692,0.09780409362952858,-0.001844414094779423,0.0020794753701400825,-0.00046187185564983135,0.009088728431803084,-0.007402191096991251,-0.0032035093070800214,-0.39621287080689904
435,2022-03-30,"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",GSK,0.009470833167708692,0.09780409362952858,-0.001844414094779423,0.0020794753701400825,-0.00046187185564983135,0.009088728431803084,-0.007402191096991251,-0.0032035093070800214,-0.39621287080689904
436,2022-04-18,"As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ",GSK,-0.0025906360981022836,-0.34842598794373747,-0.01131267078877174,0.006877297903961299,0.0010756803849041319,-0.0034304540121256055,0.008868621652589725,-0.006709980970107443,0.3098684210526317
437,2022-04-22,"Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ",GSK,-0.017946963461394128,-0.20848389910461573,-0.0032722689135231686,-0.0010895966202891794,-0.006709980970107443,-0.0025906360981022836,-0.01131267078877174,0.006017362578944807,-0.04419206117170804
438,2022-04-27,"Earnings Scheduled For April 27, 2022",GSK,0.023654015398248296,0.2618640309193436,-0.016615064459792106,0.006017362578944807,-0.017946963461394128,-0.0032722689135231686,-0.0010895966202891794,0.00660214831588668,-0.14515967061658963
439,2022-04-27,"The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis",GSK,0.023654015398248296,0.2618640309193436,-0.016615064459792106,0.006017362578944807,-0.017946963461394128,-0.0032722689135231686,-0.0010895966202891794,0.00660214831588668,-0.14515967061658963
440,2022-05-31,Unilever Jumps After Nelson Peltz Joins Board,GSK,-0.00363147796270169,0.3829683528879295,-0.008104318675952515,-0.012230430515282276,-0.0006666188283678265,0.005586513126178971,0.005166317999024672,-0.019590033547922325,-0.2289857261536138
441,2022-05-31,Unilever To Add This Activist Investor To Board - What's The Catch?,GSK,-0.00363147796270169,0.3829683528879295,-0.008104318675952515,-0.012230430515282276,-0.0006666188283678265,0.005586513126178971,0.005166317999024672,-0.019590033547922325,-0.2289857261536138
442,2022-05-31,"Morning Brief: Top Financial Stories Dominating on Tuesday, May 31",GSK,-0.00363147796270169,0.3829683528879295,-0.008104318675952515,-0.012230430515282276,-0.0006666188283678265,0.005586513126178971,0.005166317999024672,-0.019590033547922325,-0.2289857261536138
443,2022-06-01,"Morning Brief: Top Financial Stories Dominating on Wednesday, June 1",GSK,-0.019590033547922325,-0.2289857261536138,-0.00363147796270169,-0.008104318675952515,-0.012230430515282276,-0.0006666188283678265,0.005586513126178971,0.008131965419316822,-0.2981846083521076
444,2022-06-01,Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off,GSK,-0.019590033547922325,-0.2289857261536138,-0.00363147796270169,-0.008104318675952515,-0.012230430515282276,-0.0006666188283678265,0.005586513126178971,0.008131965419316822,-0.2981846083521076
445,2022-06-06,"Morning Brief: Top Financial Stories Dominating on Monday, June 6",GSK,0.002106866678445174,-0.23896145524481127,-0.015441386021869508,0.008131965419316822,-0.019590033547922325,-0.00363147796270169,-0.008104318675952515,0.033636972758813055,2.5813151521533118
446,2022-06-10,"Morning Brief: Top Financial Stories Dominating on Friday, June 10",GSK,0.01765797422056936,0.8422984562607203,-0.026244358386605326,-0.0011299808641878073,0.033636972758813055,0.002106866678445174,-0.015441386021869508,-0.029680360991463983,-0.04227882986052922
447,2022-06-13,"Morning Brief: Top Financial Stories Dominating on Monday, June 13",GSK,-0.029680360991463983,-0.04227882986052922,0.01765797422056936,-0.026244358386605326,-0.0011299808641878073,0.033636972758813055,0.002106866678445174,-0.029647060086480326,-0.22254411121372675
448,2022-06-24,"Benzinga Before The Bell: Gun Safety Bill. Bill Gates North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24",GSK,0.021988259544927446,-0.3779140522514264,0.018584585800313747,0.004788189628166073,0.01211535769257921,-0.0088856786734266,-0.007389843570909216,0.0002289289285954954,-0.08605182926829269
449,2022-06-27,"The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies",GSK,0.0002289289285954954,-0.08605182926829269,0.021988259544927446,0.018584585800313747,0.004788189628166073,0.01211535769257921,-0.0088856786734266,-0.008009148581100467,0.07561226475412108
450,2022-07-18,"Benzinga Before The Bell: Amazon Wages Price War On Tesco, Biden's Campaign Promise To Free Cannabis Prisoners, H&M Exits Russia And Other Top Financial Stories Monday, July 18",GSK,-0.020363604534682778,-0.4928759435296165,0.025609035791120727,-0.017106442489529194,-0.012548185135321743,-0.019635784712597637,-0.001653226210987957,0.08661226494400065,-0.8885814781452408
451,2022-07-19,"Benzinga Before The Bell: Musk's Twitter Lawsuit, Uber Penalized For Overcharging People With Disabilities, Johnson & Johnson Cuts Outlook And Other Top Financial Stories Tuesday, July 19",GSK,0.08661226494400065,-0.8885814781452408,-0.020363604534682778,0.025609035791120727,-0.017106442489529194,-0.012548185135321743,-0.019635784712597637,-0.05260776690611091,0.18902791145332043
452,2022-07-27,"Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy",GSK,0.023988747524807952,-0.0688485218153746,0.008538846058869565,-0.0030740399728430567,0.007384563667654387,0.009134653793917202,-0.05260776690611091,-0.014010063491667779,0.29501954924157126
453,2022-07-27,"Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2",GSK,0.023988747524807952,-0.0688485218153746,0.008538846058869565,-0.0030740399728430567,0.007384563667654387,0.009134653793917202,-0.05260776690611091,-0.014010063491667779,0.29501954924157126
454,2022-07-27,IDEAYA's Cancer Candidate Shows Early Tumor Modulation,GSK,0.023988747524807952,-0.0688485218153746,0.008538846058869565,-0.0030740399728430567,0.007384563667654387,0.009134653793917202,-0.05260776690611091,-0.014010063491667779,0.29501954924157126
455,2022-07-28,"Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate",GSK,-0.014010063491667779,0.29501954924157126,0.023988747524807952,0.008538846058869565,-0.0030740399728430567,0.007384563667654387,0.009134653793917202,-0.017703309961565772,-0.20607622148807359
456,2022-08-10,"Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial",GSK,-0.043217567051069494,1.4719982326300673,-0.0069462217387439296,-0.006408733234467445,-0.0007388632375481263,-0.005389577542142199,-0.00874214822215802,-0.06710177364886549,1.2591268600026813
457,2022-08-11,Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke,GSK,-0.06710177364886549,1.2591268600026813,-0.043217567051069494,-0.0069462217387439296,-0.006408733234467445,-0.0007388632375481263,-0.005389577542142199,0.008396253405147158,-0.6617876851870166
458,2022-08-15,Landmark Drug Pricing Reform Bill Passes Congress House,GSK,-0.029974945102352657,0.28686723534375447,0.008396253405147158,-0.06710177364886549,-0.043217567051069494,-0.0069462217387439296,-0.006408733234467445,0.008869702354004083,-0.24121431678450167
459,2022-08-24,Stocks That Hit 52-Week Lows On Wednesday,GSK,-0.005929574442843588,-0.045184441408371856,-0.0093979747894255,-0.00029365755624166656,-0.005547293524346353,-0.0017198012679128238,-0.015881810302613153,0.005964944022472274,0.10217908492224947
460,2022-08-29,Stocks That Hit 52-Week Lows On Monday,GSK,-0.0024101385636347006,-0.5357492414603112,-0.016009654999555534,0.005964944022472274,-0.005929574442843588,-0.0093979747894255,-0.00029365755624166656,-0.0045304267254890895,0.0526801243872872
461,2022-08-30,Stocks That Hit 52-Week Lows On Tuesday,GSK,-0.0045304267254890895,0.0526801243872872,-0.0024101385636347006,-0.016009654999555534,0.005964944022472274,-0.005929574442843588,-0.0093979747894255,-0.014563154906605202,0.07442733758918507
462,2022-08-30,"With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report",GSK,-0.0045304267254890895,0.0526801243872872,-0.0024101385636347006,-0.016009654999555534,0.005964944022472274,-0.005929574442843588,-0.0093979747894255,-0.014563154906605202,0.07442733758918507
463,2022-09-01,Novartis Appoints Merck Executive As Research Head,GSK,-0.02432262190913914,1.8871103033692158,-0.014563154906605202,-0.0045304267254890895,-0.0024101385636347006,-0.016009654999555534,0.005964944022472274,0.0050489280568861705,-0.341976773277163
464,2022-09-02,"White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox",GSK,0.0050489280568861705,-0.341976773277163,-0.02432262190913914,-0.014563154906605202,-0.0045304267254890895,-0.0024101385636347006,-0.016009654999555534,-0.011931026596967875,-0.3114736002943521
465,2022-09-22,"Top Financial Media Stories Thursday, September 22: Facebook Sued For Bypassing Apple Privacy Rules, Walmart Slows Hiring Plans Ahead Of Holiday Season, China Blames US For Northwestern Polytechnical University Hack And More..",GSK,0.008061834042425442,0.2000731703437415,-0.023614314306749762,-0.009421733353328965,-0.0016218022697915835,-0.006125038259550353,-0.0057692498248952395,-0.021659453630313963,0.20303532374577515
466,2022-09-22,"US Stocks Could Remain Jittery Thursday Over Fed Rate Hike As S&P 500, Nasdaq Futures See Volatility  McDonald's In Focus",GSK,0.008061834042425442,0.2000731703437415,-0.023614314306749762,-0.009421733353328965,-0.0016218022697915835,-0.006125038259550353,-0.0057692498248952395,-0.021659453630313963,0.20303532374577515
467,2022-09-26,"iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26",GSK,-0.018392365248859566,0.3583618875532981,-0.021659453630313963,0.008061834042425442,-0.023614314306749762,-0.009421733353328965,-0.0016218022697915835,-0.005551718561440433,-0.45965982366634495
468,2022-10-04,DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round,GSK,0.01520659811976488,0.28496970486676654,0.027862685015835664,0.0023842040800809983,-0.003394444331508928,0.02791349319857961,-0.005551718561440433,-0.009768774415762849,-0.26433605435278607
469,2022-10-05,AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial,GSK,-0.009768774415762849,-0.26433605435278607,0.01520659811976488,0.027862685015835664,0.0023842040800809983,-0.003394444331508928,0.02791349319857961,-0.013482387990494282,0.07377924807884484
470,2022-10-13,GSK Touts 'Exceptional Results' From RSV Vaccine Candidate In Older Adults,GSK,0.009219526686317536,0.023306868263374136,-0.0019717448414700023,0.007949678314713493,0.002656933360076552,0.0036666787867405404,-0.013482387990494282,0.0019575922262691225,-0.10425034276957823
471,2022-10-13,"US Stocks Show Cautious Optimism As S&P 500, Dow Futures Surge Ahead Of Key CPI Data  Trump's SPAC Partner, Applied Materials And Chip Stocks In Focus Today",GSK,0.009219526686317536,0.023306868263374136,-0.0019717448414700023,0.007949678314713493,0.002656933360076552,0.0036666787867405404,-0.013482387990494282,0.0019575922262691225,-0.10425034276957823
472,2022-10-13,"Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13",GSK,0.009219526686317536,0.023306868263374136,-0.0019717448414700023,0.007949678314713493,0.002656933360076552,0.0036666787867405404,-0.013482387990494282,0.0019575922262691225,-0.10425034276957823
473,2022-10-20,Boston University's COVID-19 Created In Lab Research Comes Under Scrutiny,GSK,-0.007984696211108755,-0.3077415526825308,0.001919944110879257,-0.0015973873268554373,0.019211984221956246,0.0019575922262691225,0.009219526686317536,0.026078645788208288,0.6193752114582158
474,2022-11-02,"Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02",GSK,-0.010161304756624912,-0.1162981369593461,0.008742928772107028,-0.003005837749282536,0.016809287466484024,0.0009177744297219625,0.013957680903985192,-0.008454134074145414,-0.21797342240111905
475,2022-11-16,"Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says",GSK,0.019200993238087882,-0.03348080179146873,-0.007682758075073348,0.03039896463020142,-0.05646849194042558,0.03238746397737735,0.006207224176274506,-9.205014097612985e-05,-0.3352546714888487
476,2022-11-25,European Official Says COVID-19 Booster Uptake Disappointing In The Region,GSK,0.008904828219443717,-0.5236992211251701,-0.004726732640373488,0.012260699491932314,0.016722336750041977,0.009205270621602368,-9.205014097612985e-05,-0.00676674775735342,3.346079027355623
477,2022-12-07,GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial,GSK,-0.027426140838833435,-0.5396281005168883,0.07849823332585926,-0.00537476491599953,0.009135020591397147,0.01272043022724989,0.006693768738971206,-0.007592289768302729,-0.394958161211736
478,2022-12-07,"Meta Criticized For Providing Extra Protection To Certain Users, Twitter HQ Bedrooms Under Regulatory Scrutiny, Juul Settles Over 5,000 Lawsuits: Top Stories Wednesday, Dec. 07",GSK,-0.027426140838833435,-0.5396281005168883,0.07849823332585926,-0.00537476491599953,0.009135020591397147,0.01272043022724989,0.006693768738971206,-0.007592289768302729,-0.394958161211736
479,2023-01-18,Jim Cramer Says This Stock Up 23% In A Month Is 'A Great Speculative Buy',GSK,-0.010404995645586612,0.3217277415482005,0.005087616247628102,0.006543435614872584,0.01384481261647319,-0.0020150222033806786,0.006081719473536973,0.01193520037561191,-0.3637489677952106
480,2023-01-18,Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today,GSK,-0.010404995645586612,0.3217277415482005,0.005087616247628102,0.006543435614872584,0.01384481261647319,-0.0020150222033806786,0.006081719473536973,0.01193520037561191,-0.3637489677952106
481,2023-01-31,"February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More",GSK,0.003986329951132239,0.23121850422754964,-0.005099146803647647,-0.0011319700288948686,0.004833716368022989,0.013544602569939501,-0.01866514414025744,0.00652313177171826,-0.01000119877382566
482,2023-02-15,JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals,GSK,-0.013588506914353982,0.8898999255344267,-0.004692187603312692,0.010881634513639327,-0.016195379327493153,0.0030285790936743773,0.004147133587256713,,
483,2023-02-15,EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue,GSK,-0.013588506914353982,0.8898999255344267,-0.004692187603312692,0.010881634513639327,-0.016195379327493153,0.0030285790936743773,0.004147133587256713,,
